
<html lang="en"     class="pb-page"  data-request-id="329d2e4a-0333-4580-a8e5-172c9f3b5d2f"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.8b00152;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety" /></meta><meta name="dc.Creator" content="Robert L.  Dow" /></meta><meta name="dc.Creator" content="Mark  Ammirati" /></meta><meta name="dc.Creator" content="Scott W.  Bagley" /></meta><meta name="dc.Creator" content="Samit K.  Bhattacharya" /></meta><meta name="dc.Creator" content="Leonard  Buckbinder" /></meta><meta name="dc.Creator" content="Christian  Cortes" /></meta><meta name="dc.Creator" content="Ayman F.  El-Kattan" /></meta><meta name="dc.Creator" content="Kristen  Ford" /></meta><meta name="dc.Creator" content="Gary B.  Freeman" /></meta><meta name="dc.Creator" content="Cristiano R. W.  Guimarães" /></meta><meta name="dc.Creator" content="Shenping  Liu" /></meta><meta name="dc.Creator" content="Mark  Niosi" /></meta><meta name="dc.Creator" content="Athanasia  Skoura" /></meta><meta name="dc.Creator" content="David  Tess" /></meta><meta name="dc.Description" content="Studies have linked the serine-threonine kinase MAP4K4 to the regulation of a number of biological processes and/or diseases, including diabetes, cancer, inflammation, and angiogenesis. With a majo..." /></meta><meta name="Description" content="Studies have linked the serine-threonine kinase MAP4K4 to the regulation of a number of biological processes and/or diseases, including diabetes, cancer, inflammation, and angiogenesis. With a majo..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 23, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00152" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00152" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00152" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00152" /></link>
        
    
    

<title>2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00152" /></meta><meta property="og:title" content="2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0013.jpeg" /></meta><meta property="og:description" content="Studies have linked the serine-threonine kinase MAP4K4 to the regulation of a number of biological processes and/or diseases, including diabetes, cancer, inflammation, and angiogenesis. With a majority of the members of our lead series (e.g., 1) suffering from time-dependent inhibition (TDI) of CYP3A4, we sought design avenues that would eliminate this risk. One such approach arose from the observation that carboxylic acid-based intermediates employed in our discovery efforts retained high MAP4K4 inhibitory potency and were devoid of the TDI risk. The medicinal chemistry effort that led to the discovery of this central nervous system-impaired inhibitor together with its preclinical safety profile is described." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00152"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00152">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00152&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00152&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00152&amp;href=/doi/10.1021/acs.jmedchem.8b00152" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3114-3125</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00139" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00156" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Robert L. Dow</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert L. Dow</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#26544944435452084a084249516656404f5c43540845494b"><span class="__cf_email__" data-cfemail="0d7f626f687f7923612369627a4d7d6b6477687f236e6260">[email protected]</span></a>. Phone: 1-617-551-3254.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+L.++Dow">Robert L. Dow</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3045-5503" title="Orcid link">http://orcid.org/0000-0002-3045-5503</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark Ammirati</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark Ammirati</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Ammirati">Mark Ammirati</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Scott W. Bagley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Scott W. Bagley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Scott+W.++Bagley">Scott W. Bagley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Samit K. Bhattacharya</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Samit K. Bhattacharya</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Samit+K.++Bhattacharya">Samit K. Bhattacharya</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leonard Buckbinder</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leonard Buckbinder</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leonard++Buckbinder">Leonard Buckbinder</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christian Cortes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christian Cortes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christian++Cortes">Christian Cortes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ayman F. El-Kattan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ayman F. El-Kattan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ayman+F.++El-Kattan">Ayman F. El-Kattan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristen Ford</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristen Ford</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristen++Ford">Kristen Ford</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gary B. Freeman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gary B. Freeman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gary+B.++Freeman">Gary B. Freeman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cristiano R. W. Guimarães</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cristiano R. W. Guimarães</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cristiano+R.+W.++Guimar%C3%A3es">Cristiano R. W. Guimarães</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Shenping Liu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Shenping Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Shenping++Liu">Shenping Liu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark Niosi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark Niosi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Groton, Connecticut 06340, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Niosi">Mark Niosi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Athanasia Skoura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Athanasia Skoura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Athanasia++Skoura">Athanasia Skoura</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">David Tess</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David Tess</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pfizer Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David++Tess">David Tess</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00152&amp;href=/doi/10.1021%2Facs.jmedchem.8b00152" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3114–3125</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 23, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>29 January 2018</li><li><span class="item_label"><b>Published</b> online</span>23 March 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00152" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00152</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3114%26pageCount%3D12%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DRobert%2BL.%2BDow%252C%2BMark%2BAmmirati%252C%2BScott%2BW.%2BBagley%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D7%26contentID%3Dacs.jmedchem.8b00152%26title%3D2-Aminopyridine-Based%2BMitogen-Activated%2BProtein%2BKinase%2BKinase%2BKinase%2BKinase%2B4%2B%2528MAP4K4%2529%2BInhibitors%253A%2BAssessment%2Bof%2BMechanism-Based%2BSafety%26numPages%3D12%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3125%26publicationDate%3DApril%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00152"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2127</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">6</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00152" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;L. Dow&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Ammirati&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;W. Bagley&quot;},{&quot;first_name&quot;:&quot;Samit&quot;,&quot;last_name&quot;:&quot;K. Bhattacharya&quot;},{&quot;first_name&quot;:&quot;Leonard&quot;,&quot;last_name&quot;:&quot;Buckbinder&quot;},{&quot;first_name&quot;:&quot;Christian&quot;,&quot;last_name&quot;:&quot;Cortes&quot;},{&quot;first_name&quot;:&quot;Ayman&quot;,&quot;last_name&quot;:&quot;F. El-Kattan&quot;},{&quot;first_name&quot;:&quot;Kristen&quot;,&quot;last_name&quot;:&quot;Ford&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;B. Freeman&quot;},{&quot;first_name&quot;:&quot;Cristiano&quot;,&quot;last_name&quot;:&quot;R. W. Guimarães&quot;},{&quot;first_name&quot;:&quot;Shenping&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Niosi&quot;},{&quot;first_name&quot;:&quot;Athanasia&quot;,&quot;last_name&quot;:&quot;Skoura&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Tess&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;3114-3125&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00152&quot;},&quot;abstract&quot;:&quot;Studies have linked the serine-threonine kinase MAP4K4 to the regulation of a number of biological processes and/or diseases, including diabetes, cancer, inflammation, and angiogenesis. With a majority of the members of our lead series (e.g., 1) suffering from time-dependent inhibition (TDI) of CYP3A4, we sought design avenues that would eliminate this risk. One such approach arose from the observation that carboxylic acid-based intermediates employed in our discovery efforts retained high MAP4K4 inhibitory potency and were devoid of the TDI risk. The medicinal chemistry effort that led to the discovery of this central nervous system-impaired inhibitor together with its preclinical safety profile is described.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00152&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00152" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00152&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00152" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00152&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00152" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00152&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00152&amp;href=/doi/10.1021/acs.jmedchem.8b00152" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00152" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00152" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00152%26sid%3Dliteratum%253Aachs%26pmid%3D29570292%26genre%3Darticle%26aulast%3DDow%26date%3D2018%26atitle%3D2-Aminopyridine-Based%2BMitogen-Activated%2BProtein%2BKinase%2BKinase%2BKinase%2BKinase%2B4%2B%2528MAP4K4%2529%2BInhibitors%253A%2BAssessment%2Bof%2BMechanism-Based%2BSafety%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D7%26spage%3D3114%26epage%3D3125%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291012" title="Organic acids">Organic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=291697" title="Safety">Safety</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/jmcmar.2018.61.issue-7/20180412/jmcmar.2018.61.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Studies have linked the serine-threonine kinase MAP4K4 to the regulation of a number of biological processes and/or diseases, including diabetes, cancer, inflammation, and angiogenesis. With a majority of the members of our lead series (e.g., <b>1</b>) suffering from time-dependent inhibition (TDI) of CYP3A4, we sought design avenues that would eliminate this risk. One such approach arose from the observation that carboxylic acid-based intermediates employed in our discovery efforts retained high MAP4K4 inhibitory potency and were devoid of the TDI risk. The medicinal chemistry effort that led to the discovery of this central nervous system-impaired inhibitor together with its preclinical safety profile is described.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4/HGK/ZCl) is a serine-threonine protein kinase<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> that has been shown to be involved in the regulation of a number of biological processes, including inflammation,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> cancer,<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> diabetes,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> and angiogenesis.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> MAP4K4 has been shown to regulate a number of cellular processes, including cell transformation, adhesion,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and motility.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6,7)</a> An impediment to understanding the signaling pathways involved in these biological effects is the lack of well-characterized targets for MAP4K4. To date, NHE1,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Arp2,<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> ERM proteins,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and FARP1<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> have been identified as phosphorylation substrates for this serine-threonine kinase. Selective inhibitors of MAP4K4 have served an important role in the initial steps of deconvoluting the signaling pathways of this kinase.<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12−14)</a></div><div class="NLM_p">Our group recently reported on a series of potent MAP4K4 inhibitors that arose from a virtual screening effort utilizing an in-house crystal structure of the kinase domain.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Optimized analogues contain a 2-aminopyridine core that establishes two points of contact with the hinge region of MAP4K4. As part of their binding to MAP4K4, these compounds also make a π–π interaction with Tyr36, which is likely a driver in forming the unusual, folded P-loop structure of this kinase.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This feature is likely a contributor to the high level of kinome selectivity observed for this series of inhibitors.</div><div class="NLM_p">In analogy to the <i>in vivo</i> response observed following treatment with a MAP4K4-siRNA,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> inhibitor <b>1</b> reversed the inflammatory response induced by endotoxin (LPS) in a rodent model.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> In a genetically obese mouse model of insulin resistance, the performance of <b>1</b> was comparable to that of the insulin sensitizer rosiglitazone in lowering blood glucose levels. While <b>1</b> possesses a number of positive attributes, analysis of its safety profile reveals several liabilities, including a positive response in the AMES genotoxicity assay and pharmacological promiscuity as demonstrated against a panel of non-kinase targets. Time-dependent inhibition (TDI) of CYP3A4 also led to drug accumulation following multiday treatments with <b>1</b>, resulting in dose-limiting toxicities. Attempts to reduce the propensity for TDI through close-in structural modification approaches did not solve this problem.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Broader profiling of structural changes to the distal aminopyridine functionality through incorporation of a range of neutral substituents to pyridyl/phenyl-based tail groups also failed to solve the TDI issue.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It is assumed that these modifications simply shifted the site of reactive species formation to the amine functionality of the aminopyridine core involved in hinge binding interactions with MAP4K4.</div><div class="NLM_p">Replacement of the distal aminopyridine ring of <b>1</b> with an aminopyrimidine moiety (<b>2</b>) suppressed time-dependent inhibition of CYP3A4, eliminating both the genotoxicity and TDI-mediated drug accumulation risks. This modification also provided an improved off-target pharmacology profile.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> On the basis of its <i>in vitro</i> safety and <i>in vivo</i> efficacy profiles, compound <b>2</b> was advanced to a rodent <i>in vivo</i> safety evaluation. Cardiovascular assessment was prioritized given the strong association of this end point toxicity with the kinase inhibitor class.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Oral dosing in telemetered rats for 5 days with <b>2</b> (25 mg/kg, b.i.d.) resulted in a number of adverse effects. Substantial weight losses (7%) and body temperature increases (0.4 °C) relative to controls were observed over the course of the study. For cardiovascular end points, maximal heart rate increases of 25 bpm, relative to controls, were induced by treatment with <b>2</b>. Given that these effects were observed at free drug concentrations close to those required for inhibition of cellular kinase activity and <i>in vivo</i> inflammatory response,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> further development of this compound was halted.</div><div class="NLM_p last">These safety findings also raised the question of whether these toxicities were driven directly through inhibition of MAP4K4, the inherent chemotype, or due to some off-target liability(ies) that had not been identified in safety pharmacology profiling. To date, there have been no other reports of <i>in vivo</i> safety evaluation of a MAP4K4 inhibitor, making it difficult to place our own results in context regarding this question. Thus, identification of an inhibitor that possessed an orthogonal off-target and/or exposure profile that could be advanced to an <i>in vivo</i> safety analysis provided the focus for the efforts disclosed here.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44576" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44576" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With earlier efforts demonstrating that a wide range of structural modifications of either <b>1</b> or <b>2</b> led to compounds that retained significant liabilities, most notably TDI, alternative design approaches were required. Most of this subsequent work focused on incorporation of polar functionality at various positions on the lead structure in an attempt to reduce the level of CYP-mediated activation and TDI. An example of this was a set of amide analogues based on <b>3</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> It was hoped that incorporation of a modestly polar, electron-withdrawing group in this terminal ring would impact the TDI potential. However, neither <b>3</b> nor a set of analogues varying the nitrogen substituents of this lead provided a balanced potency and/or reduced TDI profile. In retrospect, the TDI associated with <b>3</b> is not too surprising given that it still retains significant turnover in human liver microsomes (CL<sub>int,app</sub> = 22 μL min<sup>–1</sup> mg<sup>–1</sup>). Toward a goal of further reductions in oxidative metabolic liability, carboxylic acid intermediates <b>4</b> and <b>5</b> were evaluated. Both of these acids possessed potent MAP4K4 enzyme and modest cellular activity. The ability of this vector to tolerate an acid functionality is consistent with previous SAR on polar substituents in this position and our knowledge from MAP4K4 crystal structures.<a onclick="showRef(event, 'ref13 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref15">(13,15)</a> More importantly, these acids were devoid of a TDI liability, as measured by the change in midazolam metabolism by CYP3A4, when they were treated with a test compound in a dose responsive manner up to 60 μM. One potential explanation for the reduction in the level of CYP inhibition by these compounds could be ascribed to the electron-withdrawing effect on the presumed reactive aminopyridine core by the carboxylic acid. The relatively low level of TDI associated with <i>N</i>-acetic acid analogue <b>6</b><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> suggests that this is likely not the key driver and the reduced TDI risk can be simply ascribed to low metabolic turnover for these carboxylic acids.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enzyme and Cell Potencies and Time-Dependent Inhibition of CYP3A4 of Analogues of Compound <b>1</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0007.gif" alt="" id="GRAPHIC-d329e434-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0008.gif" alt="" id="gr7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Geometric mean of at least three independent measurements taken in triplicate.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Change in midazolam metabolism by CYP3A4 after incubation with the compound at 60 μM for 30 min.</p></div></div><div></div></div><div class="NLM_p">In general, a right shift in cellular potency is observed for all members of this series, because they are ATP-competitive and the enzymatic assay is run at Km ATP levels (10 μM) versus cell-based concentrations that are in the millimolar range.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">()</a> This was confirmed through a similar right shift in potency when the kinase assay was run in the presence of 1 mM ATP. Compound <b>5</b> inhibited MAP4K4 in a cell-based assay with an IC<sub>50</sub> of 273 nM, which was in line with the potency in the enzyme assay run in the presence of 1 mM ATP (IC<sub>50</sub> = 93 nM). This acid is highly permeable (<i>P</i><sub>app</sub> = 19 × 10<sup>–6</sup> cm/s)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and demonstrated no evidence of efflux based on PgP ratios, suggesting these properties are not drivers in the right-shifted cellular potency.</div><div class="NLM_p">To make certain that incorporation of a carboxylic acid did not adversely affect the off-target profile of this series, <b>5</b> was screened against kinome and pharmacology panels. Screening against 20 kinases at 10 μM revealed that <b>5</b> inhibited only two non-MAP4K4 family kinases, Aurora and ABL, to a substantial extent (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf" class="ext-link">Supporting Information</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Follow-up screening in cell-based systems containing these two kinases revealed that <b>5</b> had an IC<sub>50</sub> of >30 μM against each. A clean profile (IC<sub>50</sub> > 10 μM) was also observed against a panel of ∼20 common secondary pharmacologic targets (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf" class="ext-link">Supporting Information</a>). In summary, the finding that carboxylic acid substituents are compatible with potent, selective MAP4K4 inhibition provided a forward path for this chemotype, ultimately leading to the identification of an orthogonal profile that could be advanced to a safety evaluation.</div><div class="NLM_p">Given that the carboxylic acid had been incorporated at a site on the core structure that was expected to be near the solvent–protein interface when bound to MAP4K4, it raised the question of whether this group was interacting with the protein and contributing to the observed potency. To gain insight into this question, unsubstituted congener <b>7</b> was prepared. Removal of the acid led to an ∼30-fold reduction in enzyme potency, suggesting the acid functionality has a direct interaction with MAP4K4. Because attempts to generate a crystal structure of <b>5</b> bound to MAP4K4 were not successful, it is not clear what interaction(s) might be occurring between the acid and protein. Moving the carboxylic acid into position 3 (<b>8</b>) led to an only slight reduction in potency.</div><div class="NLM_p">A limited set of carboxylic acid bioisosteres were explored (<b>9–11</b>) and found to be potent inhibitors of the MAP4K4 kinase domain. A significant right shift in cellular activity was observed for all of them relative to <b>5</b>. This may in part have been driven by the reduced passive permeability of these isosteric analogues compared to that of <b>5</b> (<i>P</i><sub>app</sub> values of 2, 6, and 4 × 10<sup>–6</sup> cm/s for <b>9–11</b>, respectively). Further efforts dedicated to bioisosteric replacement were not pursued based on this profile, as well as their relatively large polar surface areas (93–110 Å<sup>2</sup>), because these properties would limit optimization efforts with regard to incorporation of additional polar substituents (e.g., modification of the chlorophenyl ring). Interestingly, tetrazole <b>11</b> also carries significant TDI risk even though it has low turnover in human microsomes (CL<sub>int,app</sub> < 8 μL min<sup>–1</sup> mg<sup>–1</sup>).</div><div class="NLM_p">Utilizing library-enabled chemistry, the structure–activity relationships for the <i>p</i>-chlorophenyl substituent were developed. Representative examples selected from the ∼120 analogues prepared are shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>. The <i>in vitro</i> profiles of the des-chloro (<b>12</b>) and <i>m</i>-chloro (<b>13</b>) analogues were slightly right-shifted relative to that of <b>5</b>. Ortho substitution on this ring with substituents possessing a range of electronic and steric properties was not well tolerated (e.g., <b>14</b>). This is consistent with MAP4K4 crystal structures bound to this class of inhibitors that reveal an extended tunnel-like region in the protein that surrounds the phenyl group with tight tolerances for the ortho vectors.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Consistent with these earlier SAR and structural studies, position 4 of this series tolerated a wide range of substituents (e.g., <b>15–19</b>). MAP4K4 residues lining this pocket are hydrophobic in nature, suggesting that heteroaromatic replacements for the chlorophenyl substituent would not be well-tolerated. This was borne out by the finding that pyrimidine <b>20</b> was >50-fold less active than <b>19</b> was. From a small set of heteroaromatic replacements, <i>N</i>-methylpyrazole <b>21</b> was identified as a potent inhibitor of the catalytic domain of MAP4K4 but was inactive in the cell assay. Given concerns around the physical properties associated with the triaryl series, replacements for the chlorophenyl ring were explored. Incorporation of a phenoxymethyl group at position 3 of the aminopyridine (<b>22</b>) led to an ∼10-fold reduction in enzyme/cellular MAP4K4 inhibitory potency. Incorporation of the regioisomeric ether linker (<b>23</b>) led to increased inhibitory potency relative to that of <b>22</b>. Cyclobutylmethyl ether <b>24</b> had potency comparable to that of the corresponding benzyl ether. This isosteric replacement of an aryl with a cyclobutyl ring is consistent with the binding pocket in this region being formed by aliphatic-based amino acid residues in MAP4K4.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Enzyme and Cell Potencies of Aryl Analogues of <b>4</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0009.gif" alt="" id="GRAPHIC-d329e613-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0010.gif" alt="" id="gr8" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Geometric mean of at least three independent measurements taken in triplicate.</p></div></div><div></div></div><div class="NLM_p">Of the analogues in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a> tested for time-dependent inhibition of CYP3A4, only ether <b>23</b> demonstrated significant activity at 60 μM (41%). The highly electron-rich nature of this particular aminopyridine is likely the driving force behind the formation of reactive intermediates. While ethers <b>23</b> and <b>24</b> demonstrated good <i>in vitro</i> inhibitory profiles, further efforts with respect to these alkoxymethylpyridine cores were not pursued given their associated TDI risk.</div><div class="NLM_p">With these early studies suggesting that the benzoic acid moiety played a significant role in both MAP4K4 inhibitory activity and suppression of TDI, our attention turned to development of the carboxylic acid SAR. Having failed to successfully obtain co-crystals of <b>5</b> or related analogues with the catalytic domain of MAP4K4, we employed an empirical approach. Homologation to acetic acid <b>25</b> maintained MAP4K4 enzymatic and cellular potency (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). While this compound had low projected human clearance based on human liver microsomes (CL<sub>int,app,scaled</sub> < 8 mL min<sup>–1</sup> kg<sup>–1</sup>), analysis in rat liver hepatocytes suggested moderate to high clearance (CL<sub>int,app</sub> = 62 μL min<sup>–1</sup> million<sup>–1</sup>). Intravenous dosing in rats confirmed this prediction (CL = 8 mL min<sup>–1</sup> kg<sup>–1</sup>, 1 mg/kg) and suggested that further <i>in vivo</i> analyses in efficacy/safety models might be hampered by this profile, especially given the low free drug fraction in this species (fu = 0.004). Regioisomeric analogue <b>26</b> also potently inhibits MAP4K4; however, kinome profiling suggested that it had reduced selectivity relative to that of <b>25</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf" class="ext-link">Supporting Information</a>). Incorporating the dimethyl substituents of <b>25</b> into carbo/heterocycles (<b>27–29</b>) preserved the potent inhibitory activity. Unlike in the case of the benzoic acid leads, conversion of the carboxylic acid in <b>27</b> to the corresponding tetrazole (<b>29</b>) did not lead to a significant reduction in cellular potency. Besides a low predicted permeability (<i>P</i><sub>app</sub> = 1 × 10<sup>–6</sup> cm/s), <b>29</b> was also found to potently inhibit phosphodiesterase 5A1 (IC<sub>50</sub> = 27 nM). Tying the benzylic position of the acetic acid pharmacophore back as part of an indane ring (<b>30</b> and <b>31</b>) also resulted in potent inhibition, with <b>30</b> being 10-fold more potent than its enantiomer. While <b>30</b> had an improved profile versus PDE 5A1 activity (IC<sub>50</sub> = 3.4 μM), it had moderate turnover in both human and rat hepatocytes (CL<sub>int,app</sub> = 12 and 67 μL min<sup>–1</sup> million<sup>–1</sup>, respectively).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Enzyme and Cell Potencies of Benzoic Acid Modifications of <b>5</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0011.gif" alt="" id="GRAPHIC-d329e751-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0012.gif" alt="" id="gr9" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Geometric mean of at least three independent measurements taken in triplicate.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Absolute stereochemistry arbitrarily assigned.</p></div></div><div></div></div><div class="NLM_p">In contrast to earlier carboxylic acid-based analogues, a 2.5 Å structure of <b>27</b> bound to the catalytic domain of MAP4K4 was successfully generated (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). In analogy to other crystal structures for this series, the aminopyridine makes acceptor–donor interactions with the hinge region of the enzyme.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The structure also reveals that the acid is interacting with the backbone N–H of Gly32, which is at the start of the P-loop structure.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This interaction assists in stabilizing this protein feature that forms the hydrophobic tunnel accommodating this series of inhibitors. The carboxylic acid is sitting at the interface of the opening of this pocket and solvent-exposed space (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Replacement of the carboxylic acid with a nitrile (<b>32</b>) results in a 300-fold reduction in MAP4K4 inhibitory potency, which is consistent with the nitrile being unable to form a productive interaction with the P-loop region of the enzyme.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure (2.5 Å resolution) of the complex between the catalytic domain of MAP4K4 and compound <b>27</b> (yellow) (Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95">5J95</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rendering of the protein surface area of the catalytic domain of MAP4K4 bound to compound <b>27</b> (yellow) (Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95">5J95</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the interactions identified from the crystal structure of <b>27</b> bound to MAP4K4, lengthening of the linker between the phenyl ring and the carboxylic acid did not appear at first to be a fruitful avenue to pursue. To assess the validity of this conclusion, propionic acid derivative <b>33</b> was prepared and screened for MAP4K4 inhibitory activity. This homologated acid retains substantial enzymatic and cellular potency, suggesting the carboxyl acid in this case may be picking up productive interactions with the protein further outside of the hydrophobic tunnel than Gly-25.</div><div class="NLM_p">Replacement of the propionic acid side chain with the isosteric oxyacetic acid (<b>34</b>) led to a 4-fold improvement in MAP4K4 enzyme inhibitory activity, but a 10-fold reduction in cellular activity relative to that of <b>33</b>. This substantial shift in cellular activity is likely not explained by differences in passive permeability (<i>P</i><sub>app</sub> values of 7 and 12 × 10<sup>–6</sup> cm/s, respectively). To further address this question, a series of analogues were prepared in which additional lipophilicity was introduced at the α-position. Methyl enantiomers <b>35</b> and <b>36</b> retain potent inhibitory activity, with <b>35</b> showing a modest improvement in cellular potency compared to that of <b>34</b>. Incorporation of a dimethyloxyacetic acid tail (<b>37</b>) led to subnanomolar enzymatic potency, as well as a further improvement in cell activity. This modification also favorably impacted turnover in human and rat hepatocytes (CL<sub>int,app</sub> values of <6 and <25 μL min<sup>–1</sup> million<sup>–1</sup>, respectively) in addition to further separation from the off-target PDE5A1 activity (IC<sub>50</sub> = 1.9 μM). To determine whether the carboxylic acid in <b>37</b> was a key driver of MAP4K4 potency, isopropyl ether <b>38</b> was prepared. In line with the earlier work around the benzoic acid analogues, removal of the carboxylate group led to an ∼3000-fold loss in enzymatic potency and an ∼25-fold right shift in cellular potency. The moderate permeability of <b>37</b> (<i>P</i><sub>app</sub> = 10 × 10<sup>–6</sup> cm/s) may be a contributing factor in the differential shift in cellular potency relative to enzymatic potency for <b>38</b>. An attempt to increase cell permeability through incorporation of a cyclopentyl ring (<b>39</b>) actually had the opposite effect (<i>P</i><sub>app</sub> = 3 × 10<sup>–6</sup> cm/s) and in fact resulted in an isolated enzyme to whole cell ratio consistent with that seen for <b>37</b>. These results further underscore the conclusion that multiple drivers are in play for this translation between these <i>in vitro</i> activities. Additional close-in structural modifications of <b>37</b>, such as <i>m</i>-isomer <b>40</b> or incorporation of a pyridine ring (<b>41</b>), in analogy to <b>1</b>, did not provide an improved profile. Finally, extension of the linker length between the phenoxy ring and carboxylic acid (<b>42</b>) resulted in modest enzymatic/cellular potency.</div><div class="NLM_p">Attempts to co-crystallize <b>37</b> with the catalytic domain of MAP4K4 were not successful. Modeling of this ligand into the crystal structure obtained with <b>27</b> suggests that it is unlikely the acid of <b>37</b> is interacting with the backbone N–H of Gly32.</div><div class="NLM_p">On the basis of its overall profile, oxyacetic acid analogue <b>37</b> was selected for further evaluation. A summary of key <i>in vitro</i>, ADME, and safety properties of this acid relative to the aminopyridine-based starting point <b>1</b> is detailed in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>. Incorporation of the carboxylic acid resulted in an improved turnover in human microsomes and/or hepatocytes, with no detectable metabolism observed for <b>37</b> in either of these systems. As for the other carboxylic acid-based analogues in this series, the risk of TDI was also eliminated, which in turn is likely responsible for the differential mutagenic risk between these two compounds, as evidenced by the AMES results. Screening (10 μM) against a panel of 58 off-target pharmacologies showed a very clean profile, with only 5-hydroxytryptamine receptor 1B and ACE showing a >50% effect. Both of these targets were evaluated in functional assays, and <b>37</b> showed no significant activity for either at concentrations of ≤30 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf" class="ext-link">Supporting Information</a>). On the basis of the selective kinome profile of related members of this series, <b>37</b> was screened in human peripheral blood cell lysates for inhibitory activity against a panel of 232 kinases (ActivX screen). Other than MAP4K4/MINK/TNIK, only STE kinome branch member germinal center kinase (GCK/MAP4K2) and the lipid kinase phosphatidylinositol-5-phosphate 4-kinase, type II, gamma (PIP4K2C) were inhibited >70% by <b>37</b> (1 μM). Comparable potencies for the close-in family members MINK and TNIK were confirmed by enzymatic screening at Km levels of ATP, with IC<sub>50</sub> values of 1.3 and <0.6 nM, respectively. Profiling against a set of 244 kinases screened in the presence of 1 mM ATP and 1 μM <b>37</b> revealed <50% inhibition by all these targets (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf" class="ext-link">Supporting Information</a>). With an IC<sub>50</sub> of 6 nM against MAP4K4 at physiological ATP concentrations, these results suggest that compound <b>37</b> possesses a high degree of kinome selectivity.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. MAP4K4/Physicochemical/ADME Profiles for <b>37</b> and <b>1</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>37</b></th><th class="colsep0 rowsep0" align="center"><b>1</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAP4K4 kinase domain IC<sub>50</sub> (nM) at 10 μM ATP<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MAP4K4 kinase domain IC<sub>50</sub> (nM) at 1 mM ATP<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">134</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cell IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">222</td><td class="colsep0 rowsep0" align="left">160</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MW/eLogD/TPSA<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">383/1.2/85</td><td class="colsep0 rowsep0" align="left">296/3.3/78</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM CL<sub>app,scaled</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"><8</td><td class="colsep0 rowsep0" align="left">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hepatocyte CL<sub>int,app</sub> (μL min<sup>–1</sup> million<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left"><4</td><td class="colsep0 rowsep0" align="left">31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">solubility (mg/mL)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 1.2</td><td class="colsep0 rowsep0" align="left">1.4<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.14<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">pH 6.5</td><td class="colsep0 rowsep0" align="left">13<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">5.8<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">permeability (×10<sup>–6</sup> cm/s)</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CYP inhibition IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">>3</td><td class="colsep0 rowsep0" align="left">>3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TDI, % inhibition (dose)<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">–4% (30 μM)</td><td class="colsep0 rowsep0" align="left">54% (30 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3% (60 μM)</td><td class="colsep0 rowsep0" align="left">61% (60 μM)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="left">∼100</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">THLE IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="left">>250</td><td class="colsep0 rowsep0" align="left">>119</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMES<a class="ref internalNav" href="#t4fn9" aria-label="i">i</a></td><td class="colsep0 rowsep0" align="left">negative</td><td class="colsep0 rowsep0" align="left">positive</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Geometric mean of at least three independent measurements taken in triplicate.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">eLogD = measured logD at pH 7.4.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Monohydrate solvate.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">Dihydrochloride salt.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">At <15% inhibition of 3 μM isoforms (3A4, 2D6, 1A2, 2C8, and 2C9).</p></div><div class="footnote" id="t4fn6"><sup><sup>f</sup></sup><p class="last">Change in midazolam metabolism after incubation with the compound for 30 min.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></p></div><div class="footnote" id="t4fn7"><sup><sup>g</sup></sup><p class="last">Measurement of potassium current in human embryonic kidney 293 (HEK293) cells stably transfected with the human ether-a-go-go-related gene (hERG) channel.</p></div><div class="footnote" id="t4fn8"><sup><sup>h</sup></sup><p class="last">Transformed human liver epithelial cell assay (THLE).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></p></div><div class="footnote" id="t4fn9"><sup><sup>i</sup></sup><p class="last">Activity in a bacterial mutagenesis assay.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></p></div></div></div><div class="NLM_p">Compound <b>37</b> was advanced to pharmacokinetic profiling in anticipation of efficacy/safety studies. Consistent with their respective microsomal turnover values, intravenous dosing in rat, dog, and non-human primate confirmed low clearance. Moderate to long half-lives were observed in all species, along with small volumes of distribution (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). Predicted human clearance based on either human microsomal/hepatocyte data or allometric scaling suggested low human clearance.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Pharmacokinetic Profile of <b>37</b></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">rat<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">dog<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">NHP<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a><sup>,</sup><a class="ref internalNav" href="#t5fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">clearance (mL min<sup>–1</sup> kg<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">0.76</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">volume (L/kg)</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.42</td><td class="colsep0 rowsep0" align="left">0.52</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Dosed at 1 mg/kg, intravenous.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Fed male Wistar Han (<i>n</i> = 2).</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Fed male beagle (<i>n</i> = 2).</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">Fasted male cynomolgus (<i>n</i> = 2).</p></div></div></div><div class="NLM_p">In preparation for <i>in vivo</i> safety evaluation of <b>37</b>, a PK/PD analysis was performed in the same model system utilized to evaluate MAP4K4-siRNA inflammatory efficacy.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Mice were dosed orally with inhibitor followed by an injection of lipopolysaccharides (LPS) after 30 min. Plasma changes in TNFα were measured at 1.5 h and the corresponding free drug levels determined (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). While TNFα levels were elevated at the lower drug doses in multiple experiments, it was assumed that it was not a drug-related effect given that the free concentrations at these doses were below the cellular IC<sub>50</sub>. Only the top two dose groups exhibited substantial suppression of TNFα release upon stimulation with LPS, which is consistent with their corresponding free exposures being greater than the MAP4K4 cellular potency of <b>37</b>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response effects of <b>37</b> on LPS-induced TNFα levels in male C57-BL/6J mice (p.o., 0.5% methylcellulose vehicle). *<i>p</i> = 0.0002, and **<i>p</i> = 0.0001. Average free concentrations of <b>37</b> are shown above each dose bar in the graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In considering additional MAP4K4 chemotypes to advance to safety studies, we found carboxylic acids afforded the potential to design in a peripherally restricted exposure profile. Exclusion from the brain would aid our understanding of whether safety signals, such as reduced food intake and body temperature, observed for <b>2</b> were centrally mediated.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> To assess whether <b>37</b> had the potential to be excluded from the brain, it was screened for efflux potential in MDCK-MDR1(NIH)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and BCRP<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> containing cell lines. In both of these assay systems, <b>37</b> exhibited a profile suggesting high efflux potential, with MDR1- and BCRP-based BA:AB ratios of 3 and 116, respectively. These results were shown to be predictive, with an average free drug brain:plasma ratio of 0.14 over a 5 h test period after an oral dose of 10 mg of <b>37</b>/kg in rats. The overall profile of this brain-impaired inhibitor led us to advance it to general toxicology and cardiovascular safety profiling.</div><div class="NLM_p">No significant changes in clinical signs were observed following a single oral dose of 500 mg of <b>37</b>/kg in rats. The average free drug concentration over this 24 h period was 143 nM. Achieving high free exposure levels in rodent species was particularly challenging given the extremely high protein binding (rat fu<sub>plasma</sub> = 0.0005). In this single-dose rat study, the <i>C</i><sub>max,free</sub> was just 250 nM. The relatively low peak concentrations for this compound help to minimize the chance of off-target effects skewing interpretation of these safety evaluations. On the basis of its clean profile in this single-dose study, <b>37</b> was advanced to a dose escalation study in dogs. Exposure was limited in this study due to emesis occurring at all doses, with <i>C</i><sub>avg,free</sub> values of 50, 85, and 293 nM at 20, 100, and 500 mg/kg, respectively. The only clinical sign observed in any of the treatment groups was mucoid feces and transient tremors in one of the two dogs receiving 500 mg/kg. To determine whether <b>37</b> was differentiated relative to the negative cardiovascular effects observed for <b>2</b>, a sling-trained dog cardiovascular evaluation was performed. No significant changes were observed during a stepwise escalating intravenous infusion of <b>37</b> for either blood pressure or heart rate at free drug concentrations ≤40-fold greater than the <i>C</i><sub>eff</sub> determined in the LPS assay. On the basis of this encouraging set of single-dose data, <b>37</b> was advanced to a 2-week rat safety study (20, 100, and 500 mg/kg/day, p.o., b.i.d. dosing). Average <i>C</i><sub>avg,free</sub> exposures at these doses on the first day of dosing were 15, 67, and 166 nM. Consistent with <b>37</b> showing no significant activity in the <i>in vitro</i> TDI assay, interanimal day 1 and 14 exposures did not vary substantially. While no effect on body weight or food intake was observed at the two lower doses, at the highest dose there was a reduction in body weight gain (0.66-fold) and food intake (0.8-fold) relative to those of control animals. By day 4, animals in the high-dose group started to exhibit a number of signs of moribundity and there was a death of one animal, leading to termination of the study. The effects observed in this group mimicked very closely what was observed in a 5-day evaluation performed in rats with <b>2</b>. As in this previous case, profound toxicity was observed at exposures close to efficacious concentrations.</div><div class="NLM_p last">The significant toxicology signals associated with <b>2</b> and <b>37</b> are suggestive of a MAP4K4-driven safety liability. This is supported by their high MAP4K4 specificity, differential exposure profiles, and the relatively low concentrations leading to these safety findings. It is important to note that these inhibitors also inhibit the other kinase family members, MINK and TNIK, which could also be contributing to the observed effects. Addressing this issue will likely require development of an allosteric MAP4K4 inhibitor. Such a compound would have the benefit of high kinome specificity, including MAP4K4 family selectivity, and the potential to achieve efficacy at much lower concentrations given its non-ATP competitive nature.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Synthesis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthesis of the inhibitors described and characterized herein relied mainly upon a Suzuki–Miyaura cross coupling reaction to form the bond between the aminopyridine core and the acidic tail aromatic ring.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Representative synthetic approaches utilized in this study can be found in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Reaction of aminopyridine-based boronate <b>43</b><a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> with bromoester <b>44</b> under standard Suzuki–Miyaura coupling conditions provided ester <b>45</b>. Cleavage of the <i>tert</i>-butyl ester with acid afforded acid <b>3</b>.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 85 °C; (ii) HCl, EtOH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure><div class="NLM_p">An alternative approach to the preparation of compounds possessing variations of the acid containing aromatic tails is to reverse the reactivity of the two partners in the Suzuki–Miyaura reaction. <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> details this approach utilized for the synthesis of <b>37</b>. Bromide <b>46</b> was converted to the corresponding boronate ester <b>47</b>. Coupling of this boronate with bromoaminopyridine <b>48</b> under Suzuki–Miyaura conditions provided ester <b>49</b>. Base hydrolysis afforded target oxyacetic acid-based derivative <b>37</b>.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-(1,3,2-dioxaborolane), Pd(dppf)Cl<sub>2</sub>, KOAc, 1,4-dioxane, 80 °C; (ii) Pd(AmPhos)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH, H<sub>2</sub>O, 60 °C; (iii) NaOH, H<sub>2</sub>O, EtOH, reflux.</p></p></figure><div class="NLM_p">An approach for rapid development of structure–activity relationships at position 3 of the aminopyridine headgroup was developed in which a late stage 3-bromo intermediate was utilized (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). This intermediate was generated via a two-step sequence involving a Suzuki–Miyaura coupling of boronic acid <b>50</b> and aminobromopyridine <b>51</b> to afford biaryl <b>52</b>. Subsequent bromination of the intermediate with <i>N</i>-bromosuccinimide provided <b>53</b> in 81% overall yield for this sequence. Coupling of this bromide with phenyboronic acid afforded ester <b>54</b>. Acid-catalyzed cleavage of the <i>tert</i>-butyl ester afforded acid <b>12</b> as the TFA salt.</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 80 °C; (ii) <i>N</i>-bromosuccinimide, CH<sub>2</sub>Cl<sub>2</sub>, room temperature; (iii) phenylboronic, Pd(dppf)Cl<sub>2</sub> acid, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 80 °C; (iv) trifluoroacetic acid, CH<sub>2</sub>Cl<sub>2</sub>, 30 °C.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70206" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70206" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Incorporation of an oxyacetic acid moiety into a lead series of MAP4K4 inhibitors afforded high target potency and selectivity. This modification also provided a significant degree of central nervous system impairment, which was viewed as a positive attribute for targeting disease end points such as diabetes and other inflammation-driven indications. While this profile was distinct when compared to those of early members of this series, a similar preclinical safety profile was still observed. These results are suggestive that inhibition of MAP4K4 and/or its closely related family members is responsible for eliciting these safety signals. Alternative approaches, such as the identification of non-ATP competitive inhibitors, would be of value in assessing this hypothesis.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by the Pfizer Institutional Animal Care and Use Committee.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> MAP4K4 Z′-Lyte Assay</h3><div class="NLM_p last">The <i>in vitro</i> kinase assay utilized human recombinant protein, the GST-tagged MAP4K4 catalytic domain, residues 1–328 (Invitrogen catalog no. PV4013), and the Z′-Lyte Ser/Thr 7 FRET peptide substrate (Invitrogen catalog no. PV3208) that is labeled with fluorescein and coumarin. This FRET assay is based on the differential sensitivity of phosphorylated and nonphosphorylated peptides to proteolytic cleavage using methods outlined by the manufacturer (Invitrogen). The assay was optimized for a MAP4K4 concentration that phosphorylated 20–40% of the Z′-Lyte Ser/Thr 7 peptide at Km ATP (10 μM, Invitrogen catalog no. PV3227) in a 90 min reaction at room temperature (RT; 1.25 nM). The 10 μL reactions were performed in a 384-well black Optiplate (PerkinElmer catalog no. 6007279) in assay buffer [50 mM HEPES (pH 7.5), 1 mM EGTA, 10 mM MgCl<sub>2</sub>, and 0.01% Brij-35 (Invitrogen catalog no. PV3189)] containing 0.5% compound/DMSO, 2 μM Z′-Lyte Ser/Thr peptide, 1.25 nM MAP4K4, and either 10 μM ATP (Km) or 1 mM ATP (“physiological levels”). The phosphorylation range was determined using 0 and 100% phosphorylation controls. ATP is omitted in 0% phosphorylation controls. The 100% phosphorylation controls used a phosphorylated standard of the Ser/Thr peptide (2 μM; Invitrogen catalog no. PV3223) in place of the enzyme, peptide, and ATP. The enzyme and compound were incubated for 30 min at RT before ATP was added. Reactions were performed for 25 min in the presence of 1 mM ATP or for 90 min in the presence of 10 μM (Km) ATP at RT (optimized to achieve 20–40% phosphorylation). At 60 min, 5 μL of Development Reagent A diluted in Development Buffer was added to each well (1:65536; Invitrogen catalog nos. PV3295 and PV3127, respectively) and incubated for 60 min at RT. The reaction is stopped with 5 μL of Stop Buffer (Invitrogen catalog no. PV3094), shaken for 30 s, and read immediately on a PerkinElmer Envision instrument in FRET mode [excitation filter, Photometric 405 (barcode 302), emission filter 1, FITC 535 (barcode 206), emission filter 2, Umbelliferone 460 (barcode 207)]. Percent inhibition was calculated on the basis of sample wells containing either DMSO only (0% inhibition) or a standard compound (100% inhibition). Compound concentration responses were fit to a four-parameter equation to determine compound IC<sub>50</sub> values.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> MAP4K4-traf2 Cell Enzyme-Linked Immunosorbent Assay (ELISA)</h3><div class="NLM_p last">The assay was designed to identify compounds inhibiting MAP4K4’s phosphorylation of serine/threonine residues on traf2. GripTite 293 MSR Cells (Life Technologies catalog no. R795-07) were maintained in complete medium (DMEM catalog no. 11965-092) with 10% FBS, 10 mM HEPES (catalog no. 15630-080), 1× MEM NEAA (catalog no. 11140-050), 600 μg/mL Geneticin (catalog no. 10131-027), and 1000 units/mL penicillin/streptomycin (catalog no. 15140-122, Life Technologies). For culturing and plating, cells were washed with cation-free DPBS (Lonza catalog no. 17-512Q) and incubated for 5 min at RT with 37 °C Versene (Life Technologies, catalog no. 15040-066). After decanting, 5 mL of 0.25% Trypsin-EDTA (Life Technologies, catalog no. 25200-056) was added and the flask gently rocked to loosen cells. Cells were passaged 1:15 in complete medium. An in-well transient transfection was performed. Cells were seeded at a density of 35000 cells/well in 100 μL of complete medium in 96-well polystyrene TC-coated plates (Corning, catalog no. 3598). After 15 min at RT, plates were moved to a 37 °C, 5% CO<sub>2</sub>, humidified incubator for 6 h. To transfect one plate of cells, 25 μL of FuGENE HD (Promega, catalog no. E2311) was added to 500 μL of OptiMEM prewarmed to 37 °C (Life Technologies, catalog no. 31985-070) and incubated for 5 min at RT; 8.75 μg of pcDNA3.1-traf2-FLAG tag (<a href="https://NM_001242559.1" class="ext-link">NM_001242559.1</a>) and 3.5 μg of pcDNA3.1-MAP4K4-myc-His tag (<a href="https://NM_021138.3" class="ext-link">NM_021138.3</a>) were added to the OptiMem mixture, gently mixed, and incubated for 15 min at RT. The DNA-Fugene mix was diluted with 2.625 mL of OptiMem, and 25 μL was dispensed to each well of plated cells. The plates were gently swirled before being moved back to the 37 °C, 5% CO<sub>2</sub>, humidified incubator for 40 h. The cells were treated with compound solubilized in DMSO, diluted in complete medium, for a final DMSO concentration of 0.25%. The plates were incubated for 1.5 h in a 37 °C, 5% CO<sub>2</sub>, humidified incubator. The plates were then decanted and washed with 150 μL of cation-free PBS per well. Then 150 μL of HNGT buffer [50 mM HEPES (pH 7.5), 150 mM NaCl, 10% glycerol, and 1% Triton-X] with 1× HALT Protease/Phosphatase Inhibitor Cocktail (Pierce, catalog no. 78447) was added to each well. Plates were heat sealed and placed on a rotary plate shaker for 15 min while being vigorously shaken, centrifuged at 3000 rpm for 5 min, and placed in a −80 °C freezer until the ELISA was performed. ELISA plates were prepared the day before the assay by coating black high-binding 96-well plates (Greiner, catalog no. 675077) with 75 μL of well anti-FLAG antibody (Sigma, catalog no. F3165) per well at a concentration of 5 μg/mL in 0.5 M carbonate/bicarbonate buffer (pH 9.6) and incubated overnight at 4 °C. The next day the anti-FLAG-coated plates were washed of primary antibody using an ELX-405 PlateWasher and wash buffer (1× TBS and 0.05% Tween 20 buffer, 5 × 100 μL/well). Plates were then blocked with 75 μL of 5% BSA per well in wash buffer for 1 h at RT. Blocking buffer was removed and cell lysate added (50 μL/well) for 1 h at RT. Plates were washed with 5 × 100 μL per well, and 50 μL of anti-phospho-threonine antibody (Cell Signaling Technology, catalog no. 9381s) diluted 1:1500 in wash buffer was added to each well and incubated for 1 h at RT. Plates were washed as described above, and then 50 μL of donkey anti-rabbit antibody (Jackson, catalog no. 711-036-152) diluted 1:4000 in wash buffer was added to each well and incubated for 1 h at RT. After washing had been performed as described above, 50 μL of 1× SuperSignal ELISA Pico Substrate (Pierce, catalog no. 37069) was added per well. Following a 5 min incubation, plates were read on a PerkinElmer Envision instrument using a 96-well luminescence protocol. Where not specified above, chemicals were purchased from Sigma. The percent inhibition was calculated on the basis of sample wells containing either DMSO only (0% inhibition) or a standard compound (100% inhibition). Compound concentration responses were fit using a four-parameter equation to calculate IC<sub>50</sub> values.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Mouse LPS Model</h3><div class="NLM_p last">Male mice (C57/Bl6) were obtained from Charles River Laboratories. Mice (<i>n</i> = 6–8 per group) were administered compound by oral gavage followed by intravenous injection (10000 units/kg) of LPS (Invitrogen, <i>Escherichia coli</i> O111:B4) 30 min later. Blood samples for TNF-α analysis were obtained by terminal cardiac bleeding 90 min post-LPS administration. Mouse plasma TNF-α concentrations were determined by an ultrasensitive MSD cytokine assay (MSD, K153BHC-1). The data are presented as means ± the standard error, and statistical analysis was performed using GraphPad Prism 5. One-way analysis of variance with Bonferroni’s post-tests were used for statistical analysis, and <i>p</i> values of <0.05 were considered statistically significant. All procedures performed on these animals were in accordance with regulations and established guidelines and were reviewed and approved by the Pfizer Institutional Animal Care and Use Committee.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Synthetic Materials and Methods</h3><div class="NLM_p">All chemicals, reagents, and solvents were purchased from commercial sources and used without further purification. All reactions were performed under an atmosphere of nitrogen unless otherwise noted. Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded with 400 and 500 MHz Varian spectrometers. Chemical shifts are reported in parts per million relative to the residual solvent signals (i.e., for CDCl<sub>3</sub> δH = 7.27 ppm, for DMSO-<i>d</i><sub>6</sub> δH = 2.50 ppm, and for CD<sub>3</sub>OD δH = 4.78 and 3.31 ppm). The peak shapes are denoted as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; br s, broad singlet. Mass spectrometry (MS) was performed via atmospheric-pressure chemical ionization (APCI) or electrospray ionization (ESI) sources. Liquid chromatography with mass spectrometry (LC–MS) was performed on an Agilent 1100 Series instrument [Waters Atlantis C18 column, 4.6 mm × 50 mm, 5 μm; 95% water/acetonitrile linear gradient to 5% water/acetonitrile over 4 min, held at 5% water/95% acetonitrile until 5.0 min, trifluoroacetic acid modifier (0.05%); flow rate of 2.0 mL/min], and ultrapressure liquid chromatography with mass spectrometry (UPLC–MS) was performed on a Waters Acquity System [Waters Acquity HSS T3 C18 column, 2.1 mm × 50 mm, 1.7 μm; 95% water/acetonitrile linear gradient to 5% water/acetonitrile over 1.0 min, held at 5% water/95% acetonitrile until 1.5 min, formic acid modifier (0.1%) or ammonia modifier (0.1%); flow rate of 1.25 mL/min]. Silica gel chromatography was performed using a medium-pressure Biotage or ISCO system using columns prepackaged by various commercial vendors, including Biotage and ISCO. Whatman precoated silica gel plates (250 μm) were used for analytical thin layer chromatography. Compound purity was determined by HPLC, with all compounds determined to be ≥95% pure. HPLC purity determination methods are described in the <a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf" class="ext-link">Supporting Information</a>. The syntheses of compounds <b>1–3</b> and <b>7</b> were previously reported.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Compound <b>37</b> (catalog no. PZ0283) is commercially available via Sigma-Aldrich.</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 6′-Amino-5′-(4-chlorophenyl)-3,3′-bipyridine-6-carboxylic Acid, Hydrochloride Salt (<b>3</b>)</h4><div class="NLM_p last">A 4 M solution of HCl in EtOAc (0.31 mL, 1.26 mmol) was added to a mixture of <b>45</b> (120 mg, 0.31 mmol) in DCM (5 mL). After the reaction mixture had been stirred at RT for 16 h, it was concentrated, and the resulting solids were triturated with DCM (10 mL) to provide the title compound (37 mg, 0.11 mmol, 35%) as a white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.2 (s, 1H), 8.65 (s, 1H), 8.4–8.3 (d, 1H), 8.35 (s, 1H), 8.2–8.1 (d, 1H), 8.2–7.9 (br s, 3H), 7.65 (br s, 4H); LC–MS [M + 1] = 326.1; purity HPLC method C, 97.1%.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 4-(6-Amino-5-phenylpyridin-3-yl)benzoic Acid, TFA Salt (<b>12</b>)</h4><div class="NLM_p last">To a solution of <b>54</b> (40 mg, 0.12 mmol) in DCM (2 mL) was added TFA (0.4 mL), and the reaction mixture was stirred at 30 °C for 1 h. Concentration afforded the title compound (30 mg, 74 μmol, 62%) as a yellow solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.45 (d, <i>J</i> = 2.0 Hz, 1H), 8.22 (d, <i>J</i> = 2.0 Hz, 1H), 7.98–8.05 (m, 2H), 7.91 (d, <i>J</i> = 8.5 Hz, 2H), 7.72 (br s, 2H), 7.48–7.61 (m, 5H); LC–MS [M + 1] = 290.9; purity HPLC method A, 98.8%.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 2-{4-[6-Amino-5-(4-chlorophenyl)pyridin-3-yl]phenoxy}-2-methylpropanoic Acid (<b>37</b>)</h4><div class="NLM_p last">A suspension of <b>49</b> (30.3 g, 73.7 mmol) in EtOH (180 mL) was treated with 4 M NaOH (55.3 mL), and the reaction mixture was heated at reflux for 45 min. Once the reflux temperature had been reached, the solids dissolved, providing a pale yellow solution. The reaction mixture was cooled to 60 °C and titrated to pH 3.5 with 5 M HCl (approximately 45 mL). A very thick, pale yellow precipitate formed, and the mixture was allowed to stir for 4 h at 60 °C. The solids were collected by filtration and dried overnight in a vacuum oven to deliver the hydrate of the title compound (26.34 g, 68.80 mmol, 93%) as a crystalline white solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.07 (br s, 1H), 8.24 (d, <i>J</i> = 2.3 Hz, 1H), 7.45–7.63 (m, 7H), 6.86 (d, <i>J</i> = 8.6 Hz, 2H), 5.75 (s, 2H), 3.32 (br s, 2H water peak), 1.52 (s, 6H); <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 175.0, 155.4, 154.3, 144.8, 136.9, 135.5, 132.0, 131.1, 130.5, 128.8, 126.5, 125.0, 119.1, 118.9, 78.5, 25.1; LC–MS [M + 1] = 383.1; purity HPLC method E, 98.1%. Anal. Calcd for C<sub>21</sub>H<sub>19</sub>ClN<sub>2</sub>O<sub>3</sub>·H<sub>2</sub>O: C, 62.92; H, 5.28; Cl, 8.84; N, 6.99. Found: C, 62.89; H, 5.26; N, 6.96.</div></div><div id="sec5_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>tert</i>-Butyl 6′-Amino-5′-(4-chlorophenyl)-3,3′-bipyridine-6-carboxylate (<b>45</b>)</h4><div class="NLM_p last">To a mixture of 3-(4-chlorophenyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridinamine (<b>43</b>)<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (150 mg, 0.45 mmol) in a 3:1 dioxane/H<sub>2</sub>O solvent (4 mL) were added <i>tert</i>-butyl 5-bromopyridine-2-carboxylate (<b>44</b>) (117 mg, 0.45 mmol), Na<sub>2</sub>CO<sub>3</sub> (96 mg, 0.91 mmol), and Pd(dppf)Cl<sub>2</sub> (33 mg, 45 μmol). After the reaction mixture had been stirred at 85 °C for 6 h, it was cooled to RT and extracted with DCM (40 mL) (in some of the experiments referencing this procedure, extraction was performed using EtOAc); the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified via silica gel chromatography (gradient from 0 to 80% EtOAc in petroleum ether) to deliver the title compound (140 mg, 0.367 mmol, 81%) as a yellow solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.01 (s, 1H), 8.46 (s, 1H), 8.3–8.2 (d, 1H), 8.0–7.9 (d, 1H), 7.78 (s, 1H), 7.55 (br s, 4H), 6.11 (s, 2H), 1.56 (s, 9H).</div></div><div id="sec5_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> Ethyl 2-(4-Bromophenoxy)-2-methylpropanoate (<b>46</b>)</h4><div class="NLM_p last">A mixture of 4-bromophenol (200 g, 1.16 mol) and K<sub>2</sub>CO<sub>3</sub> (191 g, 1.39 mol) in ethyl 2-bromo-2-methylpropanoate (400 mL) was heated at 110 °C for 48 h. The reaction mixture was cooled to RT and filtered through diatomaceous earth; the filtrate was concentrated to provide the title compound (280 g, 0.975 mol, 84%) as a colorless oil, which was used for the next step without purification.</div></div><div id="sec5_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> Ethyl 2-Methyl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]propanoate (<b>47</b>)</h4><div class="NLM_p last">This reaction was performed in two batches of the same scale. A suspension of <b>46</b> (100 g, 348 mmol), B<sub>2</sub>Pin<sub>2</sub> (88.5 g, 348 mmol), and KOAc (85.4 g, 871 mmol) in dioxane (1.5 L) was degassed and refilled with N<sub>2</sub> several times. Pd(dppf)Cl<sub>2</sub> (14.2 g, 17.4 mmol) was added, and the mixture was degassed and refilled with N<sub>2</sub> three times. The reaction mixture was heated to 80 °C for 16 h and then cooled to RT. The two batches were combined at this point, filtered, and concentrated. After the residue had been partitioned between EtOAc (3 L) and water (1.5 L), the aqueous layer was extracted with EtOAc (1 L), and the combined organic layers were washed with water (2 L) and brine (2 L), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was subjected to chromatography on silica gel (gradient from 0 to 10% EtOAc in petroleum ether), and the purified material was triturated with petroleum ether (600 mL) to deliver the title compound (110 g, 329 mmol, 47%) as a white solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.70 (d, <i>J</i> = 8.5 Hz, 2H), 6.81 (d, <i>J</i> = 8.5 Hz, 2H), 4.22 (q, <i>J</i> = 7.0 Hz, 2H), 1.62 (s, 6H), 1.33 (s, 12H), 1.23 (t, <i>J</i> = 7.3 Hz, 3H); LC–MS [M + 1] = 335.2.</div></div><div id="sec5_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> Ethyl 2-{4-[6-Amino-5-(4-chlorophenyl)pyridin-3-yl]phenoxy}-2-methylpropanoate (<b>49</b>)</h4><div class="NLM_p last">A flask containing <b>48</b> (15.0 g, 52.9 mmol), <b>47</b> (19.4 g, 58.2 mmol), Na<sub>2</sub>CO<sub>3</sub> (16.8 g, 159 mmol), and Pd(AmPhos)<sub>2</sub>Cl<sub>2</sub> (375 mg, 0.53 mmol) was purged with N<sub>2</sub>. A degassed 5:1 EtOH/H<sub>2</sub>O solvent (180 mL) was added, and the reaction mixture was heated at 60 °C for 3 h. It was then diluted with EtOH (150 mL), followed by addition of H<sub>2</sub>O (360 mL), and the resulting mixture was allowed to stir while cooling to RT. After the solution had been stirred for approximately 1 h, the precipitate was collected by filtration, and the solids were dried overnight under vacuum to deliver the title compound (21.42 g, 52.13 mmol, 99%) as a tan solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.24 (d, <i>J</i> = 2.7 Hz, 1H), 7.48–7.57 (m, 7H), 6.83 (d, <i>J</i> = 8.6 Hz, 2H), 5.75 (s, 2H), 4.18 (q, <i>J</i> = 7.0 Hz, 2H), 1.53 (s, 6H), 1.19 (t, <i>J</i> = 7.2 Hz, 3H); LC–MS [M + 1] = 411.2.</div></div><div id="sec5_4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>tert</i>-Butyl 4-(6-Aminopyridin-3-yl)benzoate (<b>52</b>)</h4><div class="NLM_p last">Dioxane (180 mL) and 2 M aqueous Na<sub>2</sub>CO<sub>3</sub> (86.7 mL, 173 mmol) were added to a mixture of 2-amino-5-bromopyridine (<b>51</b>) (10.0 g, 57.8 mmol) and [4-(<i>tert</i>-butoxycarbonyl)phenyl]boronic acid (<b>50</b>) (14.1 g, 63.6 mmol). After the solution had been degassed with N<sub>2</sub> for 10 min, Pd(dppf)Cl<sub>2</sub> (2.11 g, 2.89 mmol) was added, and the reaction mixture was heated at 80 °C for 2 h and then allowed to cool to RT. Dioxane was removed via concentration, and the aqueous residue was partitioned between water (500 mL) and EtOAc (300 mL). The aqueous layer was extracted with additional EtOAc (2 × 300 mL), and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to provide a gray solid, which was taken up in water (500 mL), acidified with 1 M HCl (100 mL), and washed with a 1:1 EtOAc/heptane solvent (2 × 300 mL). The organic washes were combined and extracted with 0.2 M HCl (250 mL), and all of the acidic aqueous layers were combined, basified with 8 M aqueous NaOH, and extracted with EtOAc (3 × 250 mL). These organic extracts were combined, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered through a pad of silica gel (250 g) in a 2 L fritted funnel, eluting with additional EtOAc (2 L). Concentration of the filtrate afforded the title compound (13.87 g, 51.3 mmol, 89%) as a tan solid: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (d, <i>J</i> = 5.5 Hz, 1H), 8.07 (d, <i>J</i> = 8.6 Hz, 2H), 7.63 (d, <i>J</i> = 8.6 Hz, 2H), 6.91 (dd, <i>J</i> = 5.3, 1.4 Hz, 1H), 6.74 (s, 1H), 4.74 (br s, 2H), 1.62 (s, 9H); LC–MS [M + 1] = 272.1.</div></div><div id="sec5_4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>tert</i>-Butyl 4-(6-Amino-5-bromopyridin-3-yl)benzoate (<b>53</b>)</h4><div class="NLM_p last">Freshly recrystallized NBS (8.78 g, 49.3 mmol) was added portionwise over 15 min to a solution of <b>52</b> (13.34 g, 49.35 mmol) in DCM (400 mL). After the reaction mixture had been stirred for 1 h at RT, it was washed with water (2 × 400 mL) and with 10% aqueous Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> (200 mL). The organic layer was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and purified using silica gel chromatography (gradient from 0 to 50% ethyl acetate in heptane). The resulting brown solid was triturated with 10% DCM in heptane (200 mL) to afford the title compound (15.74 g, 45.07 mmol, 91%) as a tan solid: <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.11 (s, 1H), 7.98 (d, <i>J</i> = 8.6 Hz, 2H), 7.51 (d, <i>J</i> = 8.6 Hz, 2H), 6.46 (s, 1H), 6.29 (s, 2H), 1.57 (s, 9H); LC–MS [M + 1] = 349.0.</div></div><div id="sec5_4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>tert</i>-Butyl 4-(6-Amino-5-phenyl-3-pyridinyl)benzoate (<b>54</b>)</h4><div class="NLM_p last">The title compound was prepared from <b>53</b> (100 mg, 0.29 mmol), phenylboronic acid (22.1 mg, 0.286 mmol), K<sub>2</sub>CO<sub>3</sub> (99 mg, 0.72 mmol), and Pd(dppf)Cl<sub>2</sub> (21.0 mg, 29 μmol) in a 3:1 dioxane/water solvent (8 mL), according to the method utilized for compound <b>45</b>, to afford a yellow oil (45 mg, 0.13 mmol, 45%): <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (d, <i>J</i> = 1.0 Hz, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 2H), 7.65 (d, <i>J</i> = 1.0 Hz, 1H), 7.60 (d, <i>J</i> = 8.0 Hz, 2H), 7.54–7.46 (m, 4H), 7.46–7.39 (m, 1H), 4.78 (br s, 2H), 1.62 (s, 9H).</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00152" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77207" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77207" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00152" class="ext-link">10.1021/acs.jmedchem.8b00152</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Additional information for the HPLC purity analysis conditions, experimental procedures for compounds <b>4–11</b>, <b>13–36</b>, and <b>38–42</b>, kinome profiles of compounds <b>25</b> and <b>26</b>, off-target profiles for compounds <b>4</b> and <b>37</b>, ACE/5HT1B functional profiles of compound <b>37</b>, ActivX kinome profile of compound <b>37</b>, and protein production, purification, and X-ray crystal structure data for compound <b>37</b> bound to the kinase domain of MAP4K4 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_001.csv">jm8b00152_si_001.csv (2.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf">jm8b00152_si_002.pdf (955.49 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates of the MAP4K4 kinase domain bound to compound <b>27</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95">5J95</a>) have been deposited with the Protein Data Bank.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b00152" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert L. Dow</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3045-5503" title="Orcid link">http://orcid.org/0000-0002-3045-5503</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#31435e535443451f5d1f555e46714157584b54431f525e5c"><span class="__cf_email__" data-cfemail="c5b7aaa7a0b7b1eba9eba1aab285b5a3acbfa0b7eba6aaa8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Ammirati</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott W. Bagley</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samit K. Bhattacharya</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonard Buckbinder</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christian Cortes</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayman F. El-Kattan</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristen Ford</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary B. Freeman</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cristiano R. W. Guimarães</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shenping Liu</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Niosi</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Athanasia Skoura</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Tess</span> - <span class="hlFld-Affiliation affiliation">Pfizer
Worldwide Research & Development, Cambridge, Massachusetts 02139, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors are current or former Pfizer employees. The design and financial support for this research were provided by Pfizer. Pfizer participated in the interpretation of data and review and approval of the publication.<br /></br><p class="inlineNote">These authors are former Pfizer employees.</p></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11247" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11247" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Hui Zhang, Allysa Dantonio, and Michael West for performing TDI evaluations; John Umland for MDR1/BCRP data; Stephen Jenkinson and Lisa Nottebaum for functional ACE inhibition analysis; Peter Burch, Jennifer Cheung, Declan Flynn, Ted Schmahai, and Eric Wolfgang for drug safety support; Kimberly Fennell for protein production; and Katherine Brighty for assistance in writing experimentals.</p></div><table summary="" class="NLM_def-list" id="DEF-LIST-d329e2197-autogenerated"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ACE</td><td class="NLM_def"><p class="first last">angiotensin converting enzyme</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BCRP</td><td class="NLM_def"><p class="first last">breast cancer resistance protein</p></td></tr><tr><td class="NLM_term">CYP3A4</td><td class="NLM_def"><p class="first last">cytochrome P450 3A4</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">bpm</td><td class="NLM_def"><p class="first last">beats per minute</p></td></tr><tr><td class="NLM_term">MDCK-MDR1</td><td class="NLM_def"><p class="first last">Madin Darby canine kidney multidrug resistant</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">PK/PD</td><td class="NLM_def"><p class="first last">pharmacokinetic/pharmacodynamic</p></td></tr><tr><td class="NLM_term">TNFα</td><td class="NLM_def"><p class="first last">tumor necrosis factor α.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_11513" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_11513" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 29 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, T. H.</span></span> <span> </span><span class="NLM_article-title">A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">2118</span>– <span class="NLM_lpage">2225</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.4.2118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1074%2Fjbc.274.4.2118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=2118-2225&author=Z.+Yaoauthor=G.+Zhouauthor=X.+S.+Wangauthor=A.+Brownauthor=K.+Dienerauthor=H.+Ganauthor=T.+H.+Tan&title=A+novel+human+STE20-related+protein+kinase%2C+HGK%2C+that+specifically+activates+the+c-Jun+N-terminal+kinase+signaling+pathway&doi=10.1074%2Fjbc.274.4.2118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.4.2118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.4.2118%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%2BS.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DDiener%26aufirst%3DK.%26aulast%3DGan%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DT.%2BH.%26atitle%3DA%2520novel%2520human%2520STE20-related%2520protein%2520kinase%252C%2520HGK%252C%2520that%2520specifically%2520activates%2520the%2520c-Jun%2520N-terminal%2520kinase%2520signaling%2520pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D2118%26epage%3D2225%26doi%3D10.1074%2Fjbc.274.4.2118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoloro, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostroff, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, M. P.</span></span> <span> </span><span class="NLM_article-title">Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1038/nature07774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1038%2Fnature07774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=19407801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=1180-1184&author=M.+Aouadiauthor=G.+J.+Teszauthor=S.+M.+Nicoloroauthor=M.+Wangauthor=M.+Chouinardauthor=E.+Sotoauthor=G.+R.+Ostroffauthor=M.+P.+Czech&title=Orally+delivered+siRNA+targeting+macrophage+Map4k4+suppresses+systemic+inflammation&doi=10.1038%2Fnature07774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation</span></div><div class="casAuthors">Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7242</span>),
    <span class="NLM_cas:pages">1180-1184</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene silencing by double-stranded RNA, denoted RNA interference, represents a new paradigm for rational drug design.  However, the transformative therapeutic potential of short interfering RNA (siRNA) has been stymied by a key obstacle-safe delivery to specified target cells in vivo.  Macrophages are particularly attractive targets for RNA interference therapy because they promote pathogenic inflammatory responses in diseases such as rheumatoid arthritis, atherosclerosis, inflammatory bowel disease and diabetes.  Here we report the engineering of β1,3-D-glucan-encapsulated siRNA particles (GeRPs) as efficient oral delivery vehicles that potently silence genes in mouse macrophages in vitro and in vivo.  Oral gavage of mice with GeRPs contg. as little as 20 μg kg-1 siRNA directed against tumor necrosis factor α (Tnf-α) depleted its mRNA in macrophages recovered from the peritoneum, spleen, liver and lung, and lowered serum Tnf-α levels.  Screening with GeRPs for inflammation genes revealed that the mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) is a previously unknown mediator of cytokine expression.  Importantly, silencing Map4k4 in macrophages in vivo protected mice from lipopolysaccharide-induced lethality by inhibiting Tnf-α and interleukin-1β prodn.  This technol. defines a new strategy for oral delivery of siRNA to attenuate inflammatory responses in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoicgkm9195HLVg90H21EOLACvtfcHk0liMAYMjh8p-ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D&md5=708368d17ae943b509affc54a156ac7f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature07774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07774%26sid%3Dliteratum%253Aachs%26aulast%3DAouadi%26aufirst%3DM.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DNicoloro%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChouinard%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DE.%26aulast%3DOstroff%26aufirst%3DG.%2BR.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DOrally%2520delivered%2520siRNA%2520targeting%2520macrophage%2520Map4k4%2520suppresses%2520systemic%2520inflammation%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D1180%26epage%3D1184%26doi%3D10.1038%2Fnature07774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMere, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jallal, B.</span></span> <span> </span><span class="NLM_article-title">The STE20 kinse HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.6.2068-2082.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1128%2FMCB.23.6.2068-2082.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=12612079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvF2isbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=2068-2082&author=J.+H.+Wrightauthor=X.+Wangauthor=G.+Manningauthor=B.+J.+LaMereauthor=P.+Leauthor=S.+Zhuauthor=D.+Khatryauthor=P.+M.+Flanaganauthor=S.+D.+Buckleyauthor=D.+B.+Whyteauthor=A.+R.+Howlettauthor=J.+R.+Bischoffauthor=K.+E.+Lipsonauthor=B.+Jallal&title=The+STE20+kinse+HGK+is+broadly+expressed+in+human+tumor+cells+and+can+modulate+cellular+transformation%2C+invasion%2C+and+adhesion&doi=10.1128%2FMCB.23.6.2068-2082.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion</span></div><div class="casAuthors">Wright, Jocelyn H.; Wang, Xueyan; Manning, Gerard; LaMere, Brandon J.; Le, Phuong; Zhu, Shirley; Khatry, Deepak; Flanagan, Peter M.; Buckley, Sharon D.; Whyte, David B.; Howlett, Anthony R.; Bischoff, James R.; Lipson, Kenneth E.; Jallal, Bahija</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2068-2082</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HGK (hepatocyte progenitor kinase-like/germinal center kinase-like kinase) is a member of the human STE20/mitogen-activated protein kinase kinase kinase kinase family of serine/threonine kinases and is the ortholog of mouse NIK (Nck-interacting kinase).  We have cloned a novel splice variant of HGK from a human tumor line and have further identified a complex family of HGK splice variants.  We showed HGK to be highly expressed in most tumor cell lines relative to normal tissue.  An active role for this kinase in transformation was suggested by an inhibition of H-RasV12-induced focus formation by expression of inactive, dominant-neg. mutants of HGK in both fibroblast and epithelial cell lines.  Expression of an inactive mutant of HGK also inhibited the anchorage-independent growth of cells yet had no effect on proliferation in monolayer culture.  Expression of HGK mutants modulated integrin receptor expression and had a striking effect on hepatocyte growth factor-stimulated epithelial cell invasion.  Together, these results suggest an important role for HGK in cell transformation and invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe0yzhWS2ACbVg90H21EOLACvtfcHk0liMAYMjh8p-ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvF2isbo%253D&md5=f50bc323f0325d625c4ded384c06102b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.6.2068-2082.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.6.2068-2082.2003%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DManning%26aufirst%3DG.%26aulast%3DLaMere%26aufirst%3DB.%2BJ.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DKhatry%26aufirst%3DD.%26aulast%3DFlanagan%26aufirst%3DP.%2BM.%26aulast%3DBuckley%26aufirst%3DS.%2BD.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DHowlett%26aufirst%3DA.%2BR.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DJallal%26aufirst%3DB.%26atitle%3DThe%2520STE20%2520kinse%2520HGK%2520is%2520broadly%2520expressed%2520in%2520human%2520tumor%2520cells%2520and%2520can%2520modulate%2520cellular%2520transformation%252C%2520invasion%252C%2520and%2520adhesion%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D2068%26epage%3D2082%26doi%3D10.1128%2FMCB.23.6.2068-2082.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruzzese, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7049</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1158%2F1078-0432.CCR-08-0381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=18981001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlens7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7043-7049&author=J.+J.+Liangauthor=H.+Wangauthor=A.+Rashidauthor=T.-H.+Tanauthor=R.+F.+Hwangauthor=S.+R.+Hamiltonauthor=J.+L.+Abbruzzeseauthor=D.+B.+Evansauthor=H.+Wang&title=Expression+of+MAP4K4+is+associated+with+worse+prognosis+in+patients+with+stage+II+pancreatic+ductal+adenocarcinoma&doi=10.1158%2F1078-0432.CCR-08-0381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Liang, John J.; Wang, Hua; Rashid, Asif; Tan, Tse-Hua; Hwang, Rosa F.; Hamilton, Stanley R.; Abbruzzese, James L.; Evans, Douglas B.; Wang, Huamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7043-7049</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Mitogen-activated protein 4 kinase 4 (MAP4K4) is a serine/threonine kinase and belongs to the mammalian STE20/MAP4K family.  Recent studies have shown that MAP4K4 is overexpressed in many types of human cancer and cancer cell lines.  MAP4K4 plays an important role in transformation, invasiveness, adhesion, and cell migration.  However, the expression of MAP4K4 and its significance in pancreatic ductal adenocarcinoma (PDA) has not been studied.  Exptl. Design: We examd. the expression of MAP4K4 by immunohistochem. using tissue microarrays consisting of 66 stage II PDA and their paired benign pancreatic tissue.  The staining results were categorized as MAP4K4-H or MAP4K4-L.  The results were correlated with clinicopathol. features and patient survival.  RESULTS: MAP4K4 was overexpressed (MAP4K4-H) in 30 of 66 (46%) PDAs and was higher than the paired benign pancreatic tissue samples (19%; P = 0.002).  The median overall and recurrence-free survival for patients with MAP4K4-H PDAs were 19.5 and 9.3 mo, resp., compared with 65.2 and 28.8 mo for patients with MAP4K4-L tumor (P = 0.02 and 0.0005, log-rank test).  MAP4K4 expression was assocd. with poor overall and recurrence-free survival in univariate anal. (P = 0.02 and 0.001).  In multivariate anal., MAP4K4 expression significantly correlated with overall and recurrence-free survival (P = 0.025 and 0.004) independent of age, tumor size, differentiation, and stage.  MAP4K4 expression was also assocd. with higher frequency of recurrence/metastasis, larger tumor size, and increased no. of pos. lymph nodes (P < 0.05).  CONCLUSION: MAP4K4 was overexpressed in about half of PDAs.  Overexpression of MAP4K4 was assocd. with worse prognosis and is a prognostic marker for stage II PDAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvNmPXk-GGJrVg90H21EOLACvtfcHk0lgd56hGpMytrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlens7fO&md5=5aa75551a71883f256b80f0522849d73</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0381%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRashid%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DT.-H.%26aulast%3DHwang%26aufirst%3DR.%2BF.%26aulast%3DHamilton%26aufirst%3DS.%2BR.%26aulast%3DAbbruzzese%26aufirst%3DJ.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DExpression%2520of%2520MAP4K4%2520is%2520associated%2520with%2520worse%2520prognosis%2520in%2520patients%2520with%2520stage%2520II%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7043%26epage%3D7049%26doi%3D10.1158%2F1078-0432.CCR-08-0381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouzakri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zierath, J. R.</span></span> <span> </span><span class="NLM_article-title">MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-α-induced insulin resistance</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">7783</span>– <span class="NLM_lpage">7789</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608602200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1074%2Fjbc.M608602200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=7783-7789&author=K.+Bouzakriauthor=J.+R.+Zierath&title=MAP4K4+gene+silencing+in+human+skeletal+muscle+prevents+tumor+necrosis+factor-%CE%B1-induced+insulin+resistance&doi=10.1074%2Fjbc.M608602200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608602200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608602200%26sid%3Dliteratum%253Aachs%26aulast%3DBouzakri%26aufirst%3DK.%26aulast%3DZierath%26aufirst%3DJ.%2BR.%26atitle%3DMAP4K4%2520gene%2520silencing%2520in%2520human%2520skeletal%2520muscle%2520prevents%2520tumor%2520necrosis%2520factor-%25CE%25B1-induced%2520insulin%2520resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D7783%26epage%3D7789%26doi%3D10.1074%2Fjbc.M608602200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyczek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastham-Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span> <span> </span><span class="NLM_article-title">MAP4K4 regulates integrin-FERM binding to control endothelial cell motility</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>519</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1038/nature14323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1038%2Fnature14323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=2015&pages=425-430&author=P.+Vitorinoauthor=S.+Yeungauthor=A.+Crowauthor=J.+Bakkeauthor=T.+Smyczekauthor=K.+Westauthor=E.+McNamaraauthor=J.+Eastham-Andersonauthor=S.+Gouldauthor=S.+F.+Harrisauthor=C.+Ndubakuauthor=W.+Ye&title=MAP4K4+regulates+integrin-FERM+binding+to+control+endothelial+cell+motility&doi=10.1038%2Fnature14323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature14323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14323%26sid%3Dliteratum%253Aachs%26aulast%3DVitorino%26aufirst%3DP.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DCrow%26aufirst%3DA.%26aulast%3DBakke%26aufirst%3DJ.%26aulast%3DSmyczek%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DMcNamara%26aufirst%3DE.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DMAP4K4%2520regulates%2520integrin-FERM%2520binding%2520to%2520control%2520endothelial%2520cell%2520motility%26jtitle%3DNature%26date%3D2015%26volume%3D519%26spage%3D425%26epage%3D430%26doi%3D10.1038%2Fnature14323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapinoso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micklash, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampton, G. M.</span></span> <span> </span><span class="NLM_article-title">A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3775</span>– <span class="NLM_lpage">3780</span>, <span class="refDoi"> DOI: 10.1073/pnas.0600040103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1073%2Fpnas.0600040103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=16537454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFWis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3775-3780&author=C.+S.+Collinsauthor=J.+Hongauthor=L.+Sapinosoauthor=T.+Zhouauthor=Z.+Liuauthor=K.+Micklashauthor=P.+G.+Schultzauthor=G.+M.+Hampton&title=A+small+interfering+RNA+screen+for+modulators+of+tumor+cell+motility+identifies+MAP4K4+as+a+promigratory+kinase&doi=10.1073%2Fpnas.0600040103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase</span></div><div class="casAuthors">Collins, Cynthia S.; Hong, Jiyong; Sapinoso, Lisa; Zhou, Yingyao; Liu, Zheng; Micklash, Kenneth; Schultz, Peter G.; Hampton, Garret M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3775-3780</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cell motility is a complex biol. process, involved in development, inflammation, homeostasis, and pathol. processes such as the invasion and metastatic spread of cancer.  Here, we describe a genomic screen designed to identify inhibitors of cell migration.  A library of 10,996 small interfering RNAs (targeting 5,234 human genes) was screened for their ability to block the migration of a highly motile ovarian carcinoma cell line, SKOV-3, by using a 384-well wound-healing assay coupled with automated microscopy and wound quantification.  Two or more small interfering RNAs against four genes, CDK7, DYRK1B, MAP4K4 (NIK/HGK) (MAP4K4, mitogen-activated protein 4 kinase 4), and SCCA-1 (SerpinB3), potently blocked the migration of SKOV-3 cells, concordant with reduced transcript levels.  Further studies of the promigratory role of MAP4K4 showed that the knockdown of this transcript inhibited the migration of multiple carcinoma cell lines, indicating a broad role in cell motility and potently suppressed the invasion of SKOV-3 cells in vitro.  The effect of MAP4K4 on cellular migration was found to be mediated through c-Jun N-terminal kinase, independent of AP1 activation and downstream transcription.  Accordingly, small mol. inhibition of c-Jun N-terminal kinase suppressed SKOV-3 cell migration, underscoring the potential therapeutic utility of mitogen-activated protein kinase pathway inhibition in cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNhFFpuIrcbVg90H21EOLACvtfcHk0ljbRiUgsSUbAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFWis7k%253D&md5=19697563ecc7112d4803e2f6ff16ec87</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600040103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600040103%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DC.%2BS.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DSapinoso%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMicklash%26aufirst%3DK.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DHampton%26aufirst%3DG.%2BM.%26atitle%3DA%2520small%2520interfering%2520RNA%2520screen%2520for%2520modulators%2520of%2520tumor%2520cell%2520motility%2520identifies%2520MAP4K4%2520as%2520a%2520promigratory%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3775%26epage%3D3780%26doi%3D10.1073%2Fpnas.0600040103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehrke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">The Nck-interacting kinase (NIK) phosphorylate the Na+-H+ exchanger NHE1 and regulates NHE1 activation by platelet-derived growth factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">31349</span>– <span class="NLM_lpage">31356</span>, <span class="refDoi"> DOI: 10.1074/jbc.M102679200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1074%2Fjbc.M102679200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=31349-31356&author=W.+Yanauthor=K.+Nehrkeauthor=J.+Choiauthor=D.+L.+Barber&title=The+Nck-interacting+kinase+%28NIK%29+phosphorylate+the+Na%2B-H%2B+exchanger+NHE1+and+regulates+NHE1+activation+by+platelet-derived+growth+factor&doi=10.1074%2Fjbc.M102679200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102679200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102679200%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DW.%26aulast%3DNehrke%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Nck-interacting%2520kinase%2520%2528NIK%2529%2520phosphorylate%2520the%2520Na%252B-H%252B%2520exchanger%2520NHE1%2520and%2520regulates%2520NHE1%2520activation%2520by%2520platelet-derived%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D31349%26epage%3D31356%26doi%3D10.1074%2Fjbc.M102679200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LeClaire, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgartner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">The Nck-interacting kinase NIK increases ARP2/3 complex activity by phosphorylating the Arp2 subunit</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1083/jcb.201404095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1083%2Fjcb.201404095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2015&pages=161-170&author=L.+L.+LeClaireauthor=M.+Ranaauthor=M.+Baumgartnerauthor=D.+L.+Barber&title=The+Nck-interacting+kinase+NIK+increases+ARP2%2F3+complex+activity+by+phosphorylating+the+Arp2+subunit&doi=10.1083%2Fjcb.201404095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201404095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201404095%26sid%3Dliteratum%253Aachs%26aulast%3DLeClaire%26aufirst%3DL.%2BL.%26aulast%3DRana%26aufirst%3DM.%26aulast%3DBaumgartner%26aufirst%3DM.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Nck-interacting%2520kinase%2520NIK%2520increases%2520ARP2%252F3%2520complex%2520activity%2520by%2520phosphorylating%2520the%2520Arp2%2520subunit%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2015%26volume%3D208%26spage%3D161%26epage%3D170%26doi%3D10.1083%2Fjcb.201404095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baumgartner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">13391</span>– <span class="NLM_lpage">13396</span>, <span class="refDoi"> DOI: 10.1073/pnas.0605950103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1073%2Fpnas.0605950103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=13391-13396&author=M.+Baumgartnerauthor=A.+L.+Sillmanauthor=E.+M.+Blackwoodauthor=J.+Srivastavaauthor=N.+Madsonauthor=J.+W.+Schillingauthor=J.+H.+Wrightauthor=D.+L.+Barber&title=The+Nck-interacting+kinase+phosphorylates+ERM+proteins+for+formation+of+lamellipodium+by+growth+factors&doi=10.1073%2Fpnas.0605950103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0605950103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0605950103%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgartner%26aufirst%3DM.%26aulast%3DSillman%26aufirst%3DA.%2BL.%26aulast%3DBlackwood%26aufirst%3DE.%2BM.%26aulast%3DSrivastava%26aufirst%3DJ.%26aulast%3DMadson%26aufirst%3DN.%26aulast%3DSchilling%26aufirst%3DJ.%2BW.%26aulast%3DWright%26aufirst%3DJ.%2BH.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Nck-interacting%2520kinase%2520phosphorylates%2520ERM%2520proteins%2520for%2520formation%2520of%2520lamellipodium%2520by%2520growth%2520factors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D13391%26epage%3D13396%26doi%3D10.1073%2Fpnas.0605950103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwaid, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckbinder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span> <span> </span><span class="NLM_article-title">MAP4K4 is a threonine kinase that phosphorylates FARP1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2667</span>– <span class="NLM_lpage">2671</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00679</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2667-2671&author=A.+G.+Schwaidauthor=C.+Suauthor=P.+Loosauthor=J.+Wuauthor=C.+Nguyenauthor=K.+L.+Stoneauthor=J.+Kanyoauthor=K.+F.+Geogheganauthor=S.+K.+Bhattacharyaauthor=R.+L.+Dowauthor=L.+Buckbinderauthor=P.+A.+Carpino&title=MAP4K4+is+a+threonine+kinase+that+phosphorylates+FARP1&doi=10.1021%2Facschembio.5b00679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00679%26sid%3Dliteratum%253Aachs%26aulast%3DSchwaid%26aufirst%3DA.%2BG.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DLoos%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DStone%26aufirst%3DK.%2BL.%26aulast%3DKanyo%26aufirst%3DJ.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26atitle%3DMAP4K4%2520is%2520a%2520threonine%2520kinase%2520that%2520phosphorylates%2520FARP1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2667%26epage%3D2671%26doi%3D10.1021%2Facschembio.5b00679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesudason, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyczek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of GNE-495, a potent and selective MAP4K4 inhibitor with efficacy in retinal angiogenesis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyitLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=913-918&author=C.+O.+Ndubakuauthor=T.+D.+Crawfordauthor=H.+Chenauthor=J.+W.+Boggsauthor=J.+Drobnickauthor=S.+F.+Harrisauthor=R.+Jesudasonauthor=E.+McNamaraauthor=J.+Nonomiyaauthor=A.+Sambroneauthor=S.+Schmidtauthor=T.+Smyczekauthor=P.+Vitorinoauthor=L.+Wangauthor=P.+Wuauthor=S.+Yeungauthor=J.+Chenauthor=K.+Chenauthor=C.+Z.+Dingauthor=T.+Wangauthor=Z.+Xuauthor=S.+E.+Gouldauthor=L.+J.+Murrayauthor=W.+Ye&title=Structure-based+design+of+GNE-495%2C+a+potent+and+selective+MAP4K4+inhibitor+with+efficacy+in+retinal+angiogenesis&doi=10.1021%2Facsmedchemlett.5b00174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis</span></div><div class="casAuthors">Ndubaku, Chudi O.; Crawford, Terry D.; Chen, Huifen; Boggs, Jason W.; Drobnick, Joy; Harris, Seth F.; Jesudason, Rajiv; McNamara, Erin; Nonomiya, Jim; Sambrone, Amy; Schmidt, Stephen; Smyczek, Tanya; Vitorino, Philip; Wang, Lan; Wu, Ping; Yeung, Stacey; Chen, Jinhua; Chen, Kevin; Ding, Charles Z.; Wang, Tao; Xu, Zijin; Gould, Stephen E.; Murray, Lesley J.; Ye, Weilan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">913-918</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diverse biol. roles for mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) have necessitated the identification of potent inhibitors to study its function in various disease contexts.  In particular, compds. that can be used to carry out such studies in vivo would be crit. for elucidating the potential for therapeutic intervention.  A structure-based design effort coupled with property-guided optimization directed at minimizing the ability of the inhibitors to cross into the CNS led to an advanced compd. (I; GNE-495) that showed excellent potency and good PK and was used to demonstrate in vivo efficacy in a retinal angiogenesis model recapitulating effects that were obsd. in the inducible Map4k4 knockout mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7caqOoftyhLVg90H21EOLACvtfcHk0lgBpGxpUiPwzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyitLrN&md5=fbda60a194fb2b4fb73f0e16dd8438e8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00174%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBoggs%26aufirst%3DJ.%2BW.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DJesudason%26aufirst%3DR.%26aulast%3DMcNamara%26aufirst%3DE.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSmyczek%26aufirst%3DT.%26aulast%3DVitorino%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DMurray%26aufirst%3DL.%2BJ.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DStructure-based%2520design%2520of%2520GNE-495%252C%2520a%2520potent%2520and%2520selective%2520MAP4K4%2520inhibitor%2520with%2520efficacy%2520in%2520retinal%2520angiogenesis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D913%26epage%3D918%26doi%3D10.1021%2Facsmedchemlett.5b00174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammirati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagley, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckbinder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimarães, C. R.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPerle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of an in vivo tool to establish proof-of-concept for MAP4K4-based antidiabetic treatment</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1128-1133&author=M.+Ammiratiauthor=S.+W.+Bagleyauthor=S.+K.+Bhattacharyaauthor=L.+Buckbinderauthor=A.+A.+Carloauthor=R.+Conradauthor=C.+Cortesauthor=R.+L.+Dowauthor=M.+S.+Dowlingauthor=A.+El-Kattanauthor=K.+Fordauthor=C.+R.%0AW.+Guimar%C3%A3esauthor=D.+Hepworthauthor=W.+Jiaoauthor=J.+LaPerleauthor=S.+Liuauthor=A.+Londreganauthor=P.+M.+Loriaauthor=A.+M.+Mathiowetzauthor=M.+Munchhofauthor=S.+T.+M.+Orrauthor=D.+N.+Petersenauthor=D.+A.+Priceauthor=A.+Skouraauthor=A.+C.+Smithauthor=J.+Wang&title=Discovery+of+an+in+vivo+tool+to+establish+proof-of-concept+for+MAP4K4-based+antidiabetic+treatment&doi=10.1021%2Facsmedchemlett.5b00215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00215%26sid%3Dliteratum%253Aachs%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DBagley%26aufirst%3DS.%2BW.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DCarlo%26aufirst%3DA.%2BA.%26aulast%3DConrad%26aufirst%3DR.%26aulast%3DCortes%26aufirst%3DC.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DK.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DJiao%26aufirst%3DW.%26aulast%3DLaPerle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLondregan%26aufirst%3DA.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DMunchhof%26aufirst%3DM.%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DPetersen%26aufirst%3DD.%2BN.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DSkoura%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520in%2520vivo%2520tool%2520to%2520establish%2520proof-of-concept%2520for%2520MAP4K4-based%2520antidiabetic%2520treatment%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1128%26epage%3D1133%26doi%3D10.1021%2Facsmedchemlett.5b00215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">12398</span>– <span class="NLM_lpage">12403</span>, <span class="refDoi"> DOI: 10.1002/anie.201501515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1002%2Fanie.201501515" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=12398-12403&author=P.+Schr%C3%B6derauthor=T.+F%C3%B6rsterauthor=S.+Kleineauthor=C.+Beckerauthor=A.+Richtersauthor=S.+Zieglerauthor=D.+Rauhauthor=K.+Kumarauthor=H.+Waldmann&title=Neuritogenic+militarinone-inspired+4-hydroxypyridones+target+the+stress+pathway+kinase+MAP4K4&doi=10.1002%2Fanie.201501515"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201501515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201501515%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DP.%26aulast%3DF%25C3%25B6rster%26aufirst%3DT.%26aulast%3DKleine%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DRichters%26aufirst%3DA.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DNeuritogenic%2520militarinone-inspired%25204-hydroxypyridones%2520target%2520the%2520stress%2520pathway%2520kinase%2520MAP4K4%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D12398%26epage%3D12403%26doi%3D10.1002%2Fanie.201501515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guimarães, C. R.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckbinder, L.</span></span> <span> </span><span class="NLM_article-title">Understanding the impact of the P-loop conformation on kinase selectivity</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1204</span>, <span class="refDoi"> DOI: 10.1021/ci200153c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200153c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1199-1204&author=C.+R.%0AW.+Guimar%C3%A3esauthor=B.+K.+Raiauthor=M.+J.+Munchhofauthor=S.+Liuauthor=J.+Wangauthor=S.+K.+Bhattacharyaauthor=L.+Buckbinder&title=Understanding+the+impact+of+the+P-loop+conformation+on+kinase+selectivity&doi=10.1021%2Fci200153c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the impact of the P-loop conformation on kinase selectivity</span></div><div class="casAuthors">Guimaraes, Cristiano R. W.; Rai, Brajesh K.; Munchhof, Michael J.; Liu, Shenping; Wang, Jian; Bhattacharya, Samit K.; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1199-1204</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work addresses the link between selectivity and an unusual, folded conformation for the P-loop obsd. initially for MAP4K4 kinase and subsequently for other kinases.  Statistical and computational analyses of the authors' crystal structure database demonstrated that inhibitors that induced the P-loop folded conformation tended to be more selective, esp. if they took advantage of this specific conformation by interacting more favorably with a conserved Tyr or Phe residue from the P-loop.  The role of the P-loop in the crystal structures of MAP4K4 kinase and 2 selective inhibitors was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofyL-cXXqwPLVg90H21EOLACvtfcHk0lgdSXfq-dw83w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D&md5=3179e5f43bf2534badc595dced50d8c4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fci200153c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200153c%26sid%3Dliteratum%253Aachs%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DRai%26aufirst%3DB.%2BK.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DUnderstanding%2520the%2520impact%2520of%2520the%2520P-loop%2520conformation%2520on%2520kinase%2520selectivity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D1199%26epage%3D1204%26doi%3D10.1021%2Fci200153c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoloro, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostroff, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, M. P.</span></span> <span> </span><span class="NLM_article-title">Orally delivered siRNA targeting macrophage MAP4K4 suppresses systemic inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1038/nature07774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1038%2Fnature07774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=19407801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=1180-1184&author=M.+Aouadiauthor=G.+J.+Teszauthor=S.+M.+Nicoloroauthor=M.+Wangauthor=M.+Chouinardauthor=E.+Sotoauthor=G.+R.+Ostroffauthor=M.+P.+Czech&title=Orally+delivered+siRNA+targeting+macrophage+MAP4K4+suppresses+systemic+inflammation&doi=10.1038%2Fnature07774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation</span></div><div class="casAuthors">Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7242</span>),
    <span class="NLM_cas:pages">1180-1184</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene silencing by double-stranded RNA, denoted RNA interference, represents a new paradigm for rational drug design.  However, the transformative therapeutic potential of short interfering RNA (siRNA) has been stymied by a key obstacle-safe delivery to specified target cells in vivo.  Macrophages are particularly attractive targets for RNA interference therapy because they promote pathogenic inflammatory responses in diseases such as rheumatoid arthritis, atherosclerosis, inflammatory bowel disease and diabetes.  Here we report the engineering of β1,3-D-glucan-encapsulated siRNA particles (GeRPs) as efficient oral delivery vehicles that potently silence genes in mouse macrophages in vitro and in vivo.  Oral gavage of mice with GeRPs contg. as little as 20 μg kg-1 siRNA directed against tumor necrosis factor α (Tnf-α) depleted its mRNA in macrophages recovered from the peritoneum, spleen, liver and lung, and lowered serum Tnf-α levels.  Screening with GeRPs for inflammation genes revealed that the mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) is a previously unknown mediator of cytokine expression.  Importantly, silencing Map4k4 in macrophages in vivo protected mice from lipopolysaccharide-induced lethality by inhibiting Tnf-α and interleukin-1β prodn.  This technol. defines a new strategy for oral delivery of siRNA to attenuate inflammatory responses in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoicgkm9195HLVg90H21EOLACvtfcHk0lgdSXfq-dw83w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D&md5=708368d17ae943b509affc54a156ac7f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature07774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07774%26sid%3Dliteratum%253Aachs%26aulast%3DAouadi%26aufirst%3DM.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DNicoloro%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChouinard%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DE.%26aulast%3DOstroff%26aufirst%3DG.%2BR.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DOrally%2520delivered%2520siRNA%2520targeting%2520macrophage%2520MAP4K4%2520suppresses%2520systemic%2520inflammation%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D1180%26epage%3D1184%26doi%3D10.1038%2Fnature07774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">Unpublished results on MAP4K4 enzymatic/TDI profiling of ∼60 analogues from this chemical series.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morganroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, D. R.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval)</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1007/s40264-013-0047-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1007%2Fs40264-013-0047-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=23620167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=295-316&author=R.+R.+Shahauthor=J.+Morganrothauthor=D.+R.+Shah&title=Cardiovascular+safety+of+tyrosine+kinase+inhibitors%3A+with+a+special+focus+on+cardiac+repolarisation+%28QT+interval%29&doi=10.1007%2Fs40264-013-0047-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)</span></div><div class="casAuthors">Shah, Rashmi R.; Morganroth, Joel; Shah, Devron R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">295-316</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  The development of tyrosine kinase inhibitors (TKI) represents a major milestone in oncol.  However, their use has been found to be assocd. with serious toxicities that impinge on various vital organs including the heart.  Sixteen TKIs have been approved for use in oncol. as of 30 Sept. 2012, and a large no. of others are in development or under regulatory review.  Cardiovascular safety of medicinal products is a major public health issue that has concerned all the stakeholders.  This review focuses on three specific cardiovascular safety aspects of TKIs, namely their propensity to induce QT interval prolongation, left ventricular (LV) dysfunction and hypertension (both systemic and pulmonary).  Analyses of information in drug labels, the data submitted to the regulatory authorities and the published literature show that a no. of TKIs are assocd. with these undesirable effects.  Whereas LV dysfunction and systemic hypertension are on-target effects related to the inhibition of ligand-related signalling pathways, QT interval prolongation appears to be an off-target class III electrophysiol. effect, possibly related to the presence of a fluorine-based pharmacophore.  If not adequately managed, these cardiovascular effects significantly increase the morbidity and mortality in a population already at high risk.  Hitherto, the QT effect of most QT-prolonging TKIs (except lapatinib, nilotinib, sunitinib and vandetanib) is relatively mild at clin. doses and has not led to appreciable morbidity clin.  In contrast, LV dysfunction and untreated hypertension have resulted in significant morbidity.  Inevitably, dilemmas arise in detg. the risk/benefit of a TKI therapy in an individual patient who develops any of these effects following the treatment of the TKI-sensitive cancer.  QT interval prolongation, hypertension and LV dysfunction can be managed effectively by using reliable methods of measurement and careful monitoring of patients whose clin. management requires optimization by a close collaboration between an oncologist and a cardiologist, an evolving subspecialty referred to as cardio-oncol.  Despite their potential adverse clin. impact, the effects of TKIs on hypertension and LV function are generally inadequately characterised during their development.  As has been the case with QT liability of drugs, there is now a persuasive case for a regulatory requirement to study TKIs systematically for these effects.  Furthermore, since most of these novel drugs are studied in trials with relatively small sample sizes and approved on an expedited basis, there is also a compelling case for their effective pharmacovigilance and on-going reassessment of their risk/benefit after approval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgTIlxLItaUbVg90H21EOLACvtfcHk0lhrgGXdU6yQuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsL3L&md5=7e24ea72e614d9b85a87dbc88a973c58</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs40264-013-0047-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40264-013-0047-5%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%2BR.%26aulast%3DMorganroth%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DD.%2BR.%26atitle%3DCardiovascular%2520safety%2520of%2520tyrosine%2520kinase%2520inhibitors%253A%2520with%2520a%2520special%2520focus%2520on%2520cardiac%2520repolarisation%2520%2528QT%2520interval%2529%26jtitle%3DDrug%2520Saf.%26date%3D2013%26volume%3D36%26spage%3D295%26epage%3D316%26doi%3D10.1007%2Fs40264-013-0047-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">Percent change in midazolam metabolism by CYP3A4 at 60, 30, 10, 3, and 1 μM test compound concentrations: 61, 54, 27, 14, and 16% for <b>1</b> and 3, 4, −1, −4, and −4% for <b>5</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">Apparent, intrinsic human liver microsomal clearance values for <b>1</b> and <b>3</b>–<b>5</b> of 42, <8, <8, and 14 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+F.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lhrgGXdU6yQuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BF.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">Given their high degree of ATP-site homology, members of this aminopyridine series also inhibit the other GCK family members (ZC2, TNIK, and ZC3, MINK) to a degree similar to that of MAP4K4.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span> <span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure–activity relationships and discovery strategies to mitigate drug–drug interaction risks</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4896</span>– <span class="NLM_lpage">4933</span>, <span class="refDoi"> DOI: 10.1021/jm300065h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure%E2%80%93activity+relationships+and+discovery+strategies+to+mitigate+drug%E2%80%93drug+interaction+risks&doi=10.1021%2Fjm300065h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure-Activity Relationships and Discovery Strategies To Mitigate Drug-Drug Interaction Risks</span></div><div class="casAuthors">Orr, Suvi T. M.; Ripp, Sharon L.; Ballard, T. Eric; Henderson, Jaclyn L.; Scott, Dennis O.; Obach, R. Scott; Sun, Hao; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4896-4933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of mitigating drug-drug interaction (DDI) risks, which arise from inhibition of major human cytochrome P 450 enzymes is a well-established component of the lead optimization process in drug discovery.  More recently, there has been much interest in clin. DDIs potentially arising via time- and concn.-dependent cytochrome P 450 inhibition, a phenomenon consistent with mechanism-based inactivation.  Inactivated P 450 is catalytically incompetent and must be replenished by newly synthesized protein.  Consequently, time-dependent inhibition of P450s presents a greater safety concern compared to reversible inhibition because of the increased propensity for pharmacokinetic interactions upon multiple dosing and the sustained duration of these interactions after discontinuation of the mechanism-based inactivator.  Mechanism-based or time-dependent P 450 inhibitors pose an addnl. risk of idiosyncratic drug toxicity since the mechanism of time-dependency often involves the formation of reactive metabolites, which can react with proteins other than the P 450 isoenzyme responsible for catalysis. in vitro time-dependent inhibition (TDI) of P 450 enzymes is now routinely assessed as part of lead optimization efforts in preclin. drug discovery.  However, identification of an in vitro TDI liability can raise several questions such as: What is the mechanism of TDI.  Does it involve the formation of reactive metabolites.  Is there a 1:1 correlation between P 450 TDI and RM formation (as measured from reactive metabolite trapping studies).  What is the likelihood that a P 450 time-dependent inhibitor will also cause toxicity.  What are the DDI risk mitigation options when dealing with P 450 inactivators in drug discovery - compd. progression or termination.  Several drugs exhibit in vitro TDI of P 450 enzymes, but only a fraction thereof causes clin. DDIs.  Hence, when do we initiate labor-intensive medicinal chem. efforts to design compds. devoid of P 450 TDI liability.  What are the best methods to precisely predict the likelihood of occurrence of clin. DDIs with drug candidates that inactivate P 450 enzymes.  What are (if any) the qualifying considerations for clin. progression of a P 450 time-dependent inactivator with projected clin. DDI risks.  In an effort to address these questions and hopefully provide answers to some of them, we embarked on the present venture wherein we highlight the current state-of-the-art knowledge in this field with a special emphasis on (a) available biochem. and mechanistic approaches in drug discovery to examine TDI of P 450 isoenzymes with new chem. entities, (b) structure-activity relationship studies with marketed drugs assocd. with DDIs via P 450 inactivation, (c) case studies of medicinal chem. tactics to abrogate P 450 inactivation liability, (d) strategies for progression of P 450 TDI-pos. drug candidates, and (e) the utility of in silico methodol., including the use of physiol.-based pharmacokinetic simulators, in drug discovery to predict the magnitude of clin. DDIs risks anticipated with new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDO60qqRvpS7Vg90H21EOLACvtfcHk0ljiSVpbmuFf-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D&md5=aa4aa4f633b3b4f73b3d79917327b0de</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug%25E2%2580%2593drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933%26doi%3D10.1021%2Fjm300065h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benbow, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studies</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1016%2Fj.toxlet.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=20576494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVagu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2010&pages=175-182&author=J.+W.+Benbowauthor=J.+Aubrechtauthor=M.+J.+Bankerauthor=D.+Nettletonauthor=M.+D.+Aleo&title=Predicting+safety+toleration+of+pharmaceutical+chemical+leads%3A+cytotoxicity+correlations+to+exploratory+toxicity+studies&doi=10.1016%2Fj.toxlet.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies</span></div><div class="casAuthors">Benbow, John W.; Aubrecht, Jiri; Banker, Michael J.; Nettleton, David; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The selection and application of appropriate safety screening paradigms could revolutionize the drug discovery process by reducing safety-related attrition.  While mechanism specific genotoxicity and safety pharmacol. assays are routinely used in screening, the overall value of employing nonspecific cytotoxicity assays remains controversial.  A retrospective anal. of safety findings from rat exploratory toxicity studies (4-14 days) utilizing compds. that spanned broad therapeutic targets (protease, transport, G-protein-coupled receptors, and kinase inhibitors, cGMP modulators) demonstrated that safety toleration in vivo could be approximated using cytotoxicity values.  A composite safety score was calcd. for each compd. dose based on findings in each of the following categories: systemic toleration (mortality, food consumption, and adverse clin. signs), clin. chem./hematol. parameters (deviations from normal ranges), and multiorgan pathol. (necrosis or incidence/severity of histol. change).  Binning compds. into potent (LC50 < 10 μM) and non-potent (LC50 > 100 μM) cytotoxicants in vitro showed that compared to non-potent cytotoxicants the exposure to potent cytotoxicants in vivo resulted in higher overall severity scores at lower exposures.  Correlating overall toleration for individual compds. was further refined when in vivo exposure was considered.  When av. plasma exposure (Cpave) for a compd. exceeded its mean lethal concn. (LC50) in vitro (Cpave/LC50 > 1), higher overall severity scores were achieved compared to lower exposure margins (Cpave/LC50 <0.01).  Based on this anal., the ability to select lead series and individual compds. with better safety characteristics is presented.  In summary, cytotoxicity screening can be used to approx., not define, the safety characteristics of lead pharmaceutical series early in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUhD17guOBELVg90H21EOLACvtfcHk0ljiSVpbmuFf-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVagu7s%253D&md5=0740fad66ffc69226d1e9971fab41ef5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DBenbow%26aufirst%3DJ.%2BW.%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DNettleton%26aufirst%3DD.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DPredicting%2520safety%2520toleration%2520of%2520pharmaceutical%2520chemical%2520leads%253A%2520cytotoxicity%2520correlations%2520to%2520exploratory%2520toxicity%2520studies%26jtitle%3DToxicol.%2520Lett.%26date%3D2010%26volume%3D197%26spage%3D175%26epage%3D182%26doi%3D10.1016%2Fj.toxlet.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aubrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persaud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, W. W.</span></span> <span> </span><span class="NLM_article-title">Bioluminescent Salmonella reverse mutation assay: a screen for detecting mutagenicity with high throughput attributes</span>. <i>Mutagenesis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1093/mutage/gem022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1093%2Fmutage%2Fgem022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=335-342&author=J.+Aubrechtauthor=J.+J.+Osowskiauthor=P.+Persaudauthor=J.+R.+Cheungauthor=J.+Ackermanauthor=S.+H.+Lopesauthor=W.+W.+Ku&title=Bioluminescent+Salmonella+reverse+mutation+assay%3A+a+screen+for+detecting+mutagenicity+with+high+throughput+attributes&doi=10.1093%2Fmutage%2Fgem022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2Fgem022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252Fgem022%26sid%3Dliteratum%253Aachs%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DOsowski%26aufirst%3DJ.%2BJ.%26aulast%3DPersaud%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DJ.%2BR.%26aulast%3DAckerman%26aufirst%3DJ.%26aulast%3DLopes%26aufirst%3DS.%2BH.%26aulast%3DKu%26aufirst%3DW.%2BW.%26atitle%3DBioluminescent%2520Salmonella%2520reverse%2520mutation%2520assay%253A%2520a%2520screen%2520for%2520detecting%2520mutagenicity%2520with%2520high%2520throughput%2520attributes%26jtitle%3DMutagenesis%26date%3D2007%26volume%3D22%26spage%3D335%26epage%3D342%26doi%3D10.1093%2Fmutage%2Fgem022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="note"><p class="first last">Following completion of our work, there was a report of an alternative approach to peripherally restricted MAP4K4 inhibitors (ref <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span> <span> </span><span class="NLM_article-title">In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2012</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1124%2Fdmd.113.053868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=24009309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2012-2017&author=R.+Kikuchiauthor=S.+M.+de+Moraisauthor=J.+C.+Kalvass&title=In+vitro+P-glycoprotein+efflux+ratio+can+predict+the+in+vivo+brain+penetration+regardless+of+biopharmaceutics+drug+disposition+classification+system+class&doi=10.1124%2Fdmd.113.053868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class</span></div><div class="casAuthors">Kikuchi, Ryota; de Morais, Sonia M.; Kalvass, J. Cory</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2012-2017</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) is expressed at the blood-brain barrier (BBB) and restricts the penetration of its substrates into the central nervous system (CNS).  In vitro substrate assessment for P-gp is frequently used to predict the in vivo relevance of P-gp-mediated efflux at the BBB.  We have conducted a comprehensive review of literature focusing on the in vitro-in vivo correlation of P-gp efflux ratio (ER), and demonstrated that in vitro substrates of P-gp are also in vivo substrates at the BBB.  It was of note that the in vitro ER in the MDCK-MDR1 cell line from National Institutes of Health was found to be a better predictor of in vivo ER than that from Netherlands Cancer Institute, with r2 values of 0.813 and 0.531, resp.  Recently, a research group proposed that 98% of Biopharmaceutics Drug Disposition Classification System (BDDCS) class 1 drugs can penetrate the brain even when those compds. are shown as P-gp substrates in vitro.  However, our data anal. suggested that in vitro ER can predict the in vivo brain penetration regardless of the class in BDDCS.  Considering that very few marketed CNS drugs are in vivo substrates for P-gp, the in vitro substrate assessment of P-gp should be used in the early stages of drug discovery to select compds. that are most likely to penetrate the CNS to exert their pharmacol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFQtEu5USc2LVg90H21EOLACvtfcHk0lghl4nJ_0-_ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO&md5=f4e32455375b1bd684ba38174a71657c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053868%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520efflux%2520ratio%2520can%2520predict%2520the%2520in%2520vivo%2520brain%2520penetration%2520regardless%2520of%2520biopharmaceutics%2520drug%2520disposition%2520classification%2520system%2520class%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D2012%26epage%3D2017%26doi%3D10.1124%2Fdmd.113.053868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelesky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (gleevac), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-0407288) in mice</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">955</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.024489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1124%2Fdmd.108.024489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=946-955&author=L.+Zhouauthor=K.+Schmidtauthor=F.+R.+Nelsonauthor=V.+Zeleskyauthor=M.+D.+Troutmanauthor=B.+Feng&title=The+effect+of+breast+cancer+resistance+protein+and+P-glycoprotein+on+the+brain+penetration+of+flavopiridol%2C+imatinib+mesylate+%28gleevac%29%2C+prazosin%2C+and+2-methoxy-3-%284-%282-%285-methyl-2-phenyloxazol-4-yl%29ethoxy%29phenyl%29propanoic+acid+%28PF-0407288%29+in+mice&doi=10.1124%2Fdmd.108.024489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024489%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DZelesky%26aufirst%3DV.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DThe%2520effect%2520of%2520breast%2520cancer%2520resistance%2520protein%2520and%2520P-glycoprotein%2520on%2520the%2520brain%2520penetration%2520of%2520flavopiridol%252C%2520imatinib%2520mesylate%2520%2528gleevac%2529%252C%2520prazosin%252C%2520and%25202-methoxy-3-%25284-%25282-%25285-methyl-2-phenyloxazol-4-yl%2529ethoxy%2529phenyl%2529propanoic%2520acid%2520%2528PF-0407288%2529%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D946%26epage%3D955%26doi%3D10.1124%2Fdmd.108.024489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&issue=7&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lg9EtzQAJjO1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26issue%3D7%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':[],'ref18':['cit18'],'ref19':[],'ref20':[],'ref21':['cit21'],'ref22':[],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':[],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 6 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew B.  Lipner</span>, <span class="hlFld-ContribAuthor ">Xianlu L.  Peng</span>, <span class="hlFld-ContribAuthor ">Chong  Jin</span>, <span class="hlFld-ContribAuthor ">Yi  Xu</span>, <span class="hlFld-ContribAuthor ">Yanzhe  Gao</span>, <span class="hlFld-ContribAuthor ">Michael P.  East</span>, <span class="hlFld-ContribAuthor ">Naim U.  Rashid</span>, <span class="hlFld-ContribAuthor ">Richard A.  Moffitt</span>, <span class="hlFld-ContribAuthor ">Silvia G.  Herrera Loeza</span>, <span class="hlFld-ContribAuthor ">Ashley B.  Morrison</span>, <span class="hlFld-ContribAuthor ">Brian T.  Golitz</span>, <span class="hlFld-ContribAuthor ">Cyrus  Vaziri</span>, <span class="hlFld-ContribAuthor ">Lee M.  Graves</span>, <span class="hlFld-ContribAuthor ">Gary L.  Johnson</span>, <span class="hlFld-ContribAuthor ">Jen Jen  Yeh</span>. </span><span class="cited-content_cbyCitation_article-title">Irreversible JNK1-JUN inhibition by JNK-IN-8 sensitizes pancreatic cancer to 5-FU/FOLFOX chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">JCI Insight</span><span> <strong>2020,</strong> <em>5 </em>
                                    (8)
                                     <a href="https://doi.org/10.1172/jci.insight.129905" title="DOI URL">https://doi.org/10.1172/jci.insight.129905</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1172/jci.insight.129905&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1172%2Fjci.insight.129905%26sid%3Dliteratum%253Aachs%26jtitle%3DJCI%2520Insight%26atitle%3DIrreversible%252BJNK1-JUN%252Binhibition%252Bby%252BJNK-IN-8%252Bsensitizes%252Bpancreatic%252Bcancer%252Bto%252B5-FU%25252FFOLFOX%252Bchemotherapy%26aulast%3DLipner%26aufirst%3DMatthew%2BB.%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingbin  Kong</span>, <span class="hlFld-ContribAuthor ">Rong  Huang</span>, <span class="hlFld-ContribAuthor ">Haodan  He</span>, <span class="hlFld-ContribAuthor ">Yunxiang  Fan</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>, <span class="hlFld-ContribAuthor ">Shengjiao  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-component solvent-free cascade reaction of 2-cyanoacetamides: regioselective synthesis of pyridin-2-ones bearing quaternary centers. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2020,</strong> <em>22 </em>
                                    (1)
                                     , 256-264. <a href="https://doi.org/10.1039/C9GC03692J" title="DOI URL">https://doi.org/10.1039/C9GC03692J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9GC03692J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9GC03692J%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DMulti-component%252Bsolvent-free%252Bcascade%252Breaction%252Bof%252B2-cyanoacetamides%25253A%252Bregioselective%252Bsynthesis%252Bof%252Bpyridin-2-ones%252Bbearing%252Bquaternary%252Bcenters%26aulast%3DKong%26aufirst%3DLingbin%26date%3D2020%26date%3D2020%26volume%3D22%26issue%3D1%26spage%3D256%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pieter H.  Bos</span>, <span class="hlFld-ContribAuthor ">Emily R.  Lowry</span>, <span class="hlFld-ContribAuthor ">Jonathon  Costa</span>, <span class="hlFld-ContribAuthor ">Sebastian  Thams</span>, <span class="hlFld-ContribAuthor ">Alejandro  Garcia-Diaz</span>, <span class="hlFld-ContribAuthor ">Arie  Zask</span>, <span class="hlFld-ContribAuthor ">Hynek  Wichterle</span>, <span class="hlFld-ContribAuthor ">Brent R.  Stockwell</span>. </span><span class="cited-content_cbyCitation_article-title">Development of MAP4 Kinase Inhibitors as Motor Neuron-Protecting Agents. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2019,</strong> <em>26 </em>
                                    (12)
                                     , 1703-1715.e37. <a href="https://doi.org/10.1016/j.chembiol.2019.10.005" title="DOI URL">https://doi.org/10.1016/j.chembiol.2019.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2019.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2019.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DDevelopment%252Bof%252BMAP4%252BKinase%252BInhibitors%252Bas%252BMotor%252BNeuron-Protecting%252BAgents%26aulast%3DBos%26aufirst%3DPieter%2BH.%26date%3D2019%26volume%3D26%26issue%3D12%26spage%3D1703%26epage%3D1715.e37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura M.  Prolo</span>, <span class="hlFld-ContribAuthor ">Amy  Li</span>, <span class="hlFld-ContribAuthor ">Scott F.  Owen</span>, <span class="hlFld-ContribAuthor ">Jonathon J.  Parker</span>, <span class="hlFld-ContribAuthor ">Kara  Foshay</span>, <span class="hlFld-ContribAuthor ">Ryan T.  Nitta</span>, <span class="hlFld-ContribAuthor ">David W.  Morgens</span>, <span class="hlFld-ContribAuthor ">Sara  Bolin</span>, <span class="hlFld-ContribAuthor ">Christy M.  Wilson</span>, <span class="hlFld-ContribAuthor ">Johana C. M.  Vega L</span>, <span class="hlFld-ContribAuthor ">Emily J.  Luo</span>, <span class="hlFld-ContribAuthor ">Gigi  Nwagbo</span>, <span class="hlFld-ContribAuthor ">Allen  Waziri</span>, <span class="hlFld-ContribAuthor ">Gordon  Li</span>, <span class="hlFld-ContribAuthor ">Richard J.  Reimer</span>, <span class="hlFld-ContribAuthor ">Michael C.  Bassik</span>, <span class="hlFld-ContribAuthor ">Gerald A.  Grant</span>. </span><span class="cited-content_cbyCitation_article-title">Targeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-50160-w" title="DOI URL">https://doi.org/10.1038/s41598-019-50160-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-50160-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-50160-w%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DTargeted%252Bgenomic%252BCRISPR-Cas9%252Bscreen%252Bidentifies%252BMAP4K4%252Bas%252Bessential%252Bfor%252Bglioblastoma%252Binvasion%26aulast%3DProlo%26aufirst%3DLaura%2BM.%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan-Xuan  Du</span>, <span class="hlFld-ContribAuthor ">Quan-Xing  Zi</span>, <span class="hlFld-ContribAuthor ">Yu-Meng  Wu</span>, <span class="hlFld-ContribAuthor ">Yi  Jin</span>, <span class="hlFld-ContribAuthor ">Jun  Lin</span>, <span class="hlFld-ContribAuthor ">Sheng-Jiao  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">An environmentally benign multi-component reaction: regioselective synthesis of fluorinated 2-aminopyridines using diverse properties of the nitro group. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2019,</strong> <em>21 </em>
                                    (6)
                                     , 1505-1516. <a href="https://doi.org/10.1039/C8GC03698E" title="DOI URL">https://doi.org/10.1039/C8GC03698E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8GC03698E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8GC03698E%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DAn%252Benvironmentally%252Bbenign%252Bmulti-component%252Breaction%25253A%252Bregioselective%252Bsynthesis%252Bof%252Bfluorinated%252B2-aminopyridines%252Busing%252Bdiverse%252Bproperties%252Bof%252Bthe%252Bnitro%252Bgroup%26aulast%3DDu%26aufirst%3DXuan-Xuan%26date%3D2019%26date%3D2019%26volume%3D21%26issue%3D6%26spage%3D1505%26epage%3D1516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Crystal structure (2.5 Å resolution) of the complex between the catalytic domain of MAP4K4 and compound <b>27</b> (yellow) (Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95">5J95</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Rendering of the protein surface area of the catalytic domain of MAP4K4 bound to compound <b>27</b> (yellow) (Protein Data Bank entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95">5J95</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Dose–response effects of <b>37</b> on LPS-induced TNFα levels in male C57-BL/6J mice (p.o., 0.5% methylcellulose vehicle). *<i>p</i> = 0.0002, and **<i>p</i> = 0.0001. Average free concentrations of <b>37</b> are shown above each dose bar in the graph.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 85 °C; (ii) HCl, EtOH, CH<sub>2</sub>Cl<sub>2</sub>, room temperature.</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi-(1,3,2-dioxaborolane), Pd(dppf)Cl<sub>2</sub>, KOAc, 1,4-dioxane, 80 °C; (ii) Pd(AmPhos)<sub>2</sub>Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH, H<sub>2</sub>O, 60 °C; (iii) NaOH, H<sub>2</sub>O, EtOH, reflux.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/medium/jm-2018-001529_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-7/acs.jmedchem.8b00152/20180406/images/large/jm-2018-001529_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00152&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) Pd(dppf)Cl<sub>2</sub>, Na<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 80 °C; (ii) <i>N</i>-bromosuccinimide, CH<sub>2</sub>Cl<sub>2</sub>, room temperature; (iii) phenylboronic, Pd(dppf)Cl<sub>2</sub> acid, K<sub>2</sub>CO<sub>3</sub>, 1,4-dioxane, H<sub>2</sub>O, 80 °C; (iv) trifluoroacetic acid, CH<sub>2</sub>Cl<sub>2</sub>, 30 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i31">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55800" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55800" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 29 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diener, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, T. H.</span></span> <span> </span><span class="NLM_article-title">A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">2118</span>– <span class="NLM_lpage">2225</span>, <span class="refDoi"> DOI: 10.1074/jbc.274.4.2118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1074%2Fjbc.274.4.2118" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=2118-2225&author=Z.+Yaoauthor=G.+Zhouauthor=X.+S.+Wangauthor=A.+Brownauthor=K.+Dienerauthor=H.+Ganauthor=T.+H.+Tan&title=A+novel+human+STE20-related+protein+kinase%2C+HGK%2C+that+specifically+activates+the+c-Jun+N-terminal+kinase+signaling+pathway&doi=10.1074%2Fjbc.274.4.2118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.4.2118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.4.2118%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DZhou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DX.%2BS.%26aulast%3DBrown%26aufirst%3DA.%26aulast%3DDiener%26aufirst%3DK.%26aulast%3DGan%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DT.%2BH.%26atitle%3DA%2520novel%2520human%2520STE20-related%2520protein%2520kinase%252C%2520HGK%252C%2520that%2520specifically%2520activates%2520the%2520c-Jun%2520N-terminal%2520kinase%2520signaling%2520pathway%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D2118%26epage%3D2225%26doi%3D10.1074%2Fjbc.274.4.2118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoloro, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostroff, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, M. P.</span></span> <span> </span><span class="NLM_article-title">Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1038/nature07774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1038%2Fnature07774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=19407801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=1180-1184&author=M.+Aouadiauthor=G.+J.+Teszauthor=S.+M.+Nicoloroauthor=M.+Wangauthor=M.+Chouinardauthor=E.+Sotoauthor=G.+R.+Ostroffauthor=M.+P.+Czech&title=Orally+delivered+siRNA+targeting+macrophage+Map4k4+suppresses+systemic+inflammation&doi=10.1038%2Fnature07774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation</span></div><div class="casAuthors">Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7242</span>),
    <span class="NLM_cas:pages">1180-1184</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene silencing by double-stranded RNA, denoted RNA interference, represents a new paradigm for rational drug design.  However, the transformative therapeutic potential of short interfering RNA (siRNA) has been stymied by a key obstacle-safe delivery to specified target cells in vivo.  Macrophages are particularly attractive targets for RNA interference therapy because they promote pathogenic inflammatory responses in diseases such as rheumatoid arthritis, atherosclerosis, inflammatory bowel disease and diabetes.  Here we report the engineering of β1,3-D-glucan-encapsulated siRNA particles (GeRPs) as efficient oral delivery vehicles that potently silence genes in mouse macrophages in vitro and in vivo.  Oral gavage of mice with GeRPs contg. as little as 20 μg kg-1 siRNA directed against tumor necrosis factor α (Tnf-α) depleted its mRNA in macrophages recovered from the peritoneum, spleen, liver and lung, and lowered serum Tnf-α levels.  Screening with GeRPs for inflammation genes revealed that the mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) is a previously unknown mediator of cytokine expression.  Importantly, silencing Map4k4 in macrophages in vivo protected mice from lipopolysaccharide-induced lethality by inhibiting Tnf-α and interleukin-1β prodn.  This technol. defines a new strategy for oral delivery of siRNA to attenuate inflammatory responses in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoicgkm9195HLVg90H21EOLACvtfcHk0ljnV2GEd5cb5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D&md5=708368d17ae943b509affc54a156ac7f</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnature07774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07774%26sid%3Dliteratum%253Aachs%26aulast%3DAouadi%26aufirst%3DM.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DNicoloro%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChouinard%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DE.%26aulast%3DOstroff%26aufirst%3DG.%2BR.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DOrally%2520delivered%2520siRNA%2520targeting%2520macrophage%2520Map4k4%2520suppresses%2520systemic%2520inflammation%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D1180%26epage%3D1184%26doi%3D10.1038%2Fnature07774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manning, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaMere, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khatry, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flanagan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckley, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whyte, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howlett, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lipson, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jallal, B.</span></span> <span> </span><span class="NLM_article-title">The STE20 kinse HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion</span>. <i>Mol. Cell. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">2068</span>– <span class="NLM_lpage">2082</span>, <span class="refDoi"> DOI: 10.1128/MCB.23.6.2068-2082.2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1128%2FMCB.23.6.2068-2082.2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=12612079" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvF2isbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=2068-2082&author=J.+H.+Wrightauthor=X.+Wangauthor=G.+Manningauthor=B.+J.+LaMereauthor=P.+Leauthor=S.+Zhuauthor=D.+Khatryauthor=P.+M.+Flanaganauthor=S.+D.+Buckleyauthor=D.+B.+Whyteauthor=A.+R.+Howlettauthor=J.+R.+Bischoffauthor=K.+E.+Lipsonauthor=B.+Jallal&title=The+STE20+kinse+HGK+is+broadly+expressed+in+human+tumor+cells+and+can+modulate+cellular+transformation%2C+invasion%2C+and+adhesion&doi=10.1128%2FMCB.23.6.2068-2082.2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The STE20 kinase HGK is broadly expressed in human tumor cells and can modulate cellular transformation, invasion, and adhesion</span></div><div class="casAuthors">Wright, Jocelyn H.; Wang, Xueyan; Manning, Gerard; LaMere, Brandon J.; Le, Phuong; Zhu, Shirley; Khatry, Deepak; Flanagan, Peter M.; Buckley, Sharon D.; Whyte, David B.; Howlett, Anthony R.; Bischoff, James R.; Lipson, Kenneth E.; Jallal, Bahija</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2068-2082</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">HGK (hepatocyte progenitor kinase-like/germinal center kinase-like kinase) is a member of the human STE20/mitogen-activated protein kinase kinase kinase kinase family of serine/threonine kinases and is the ortholog of mouse NIK (Nck-interacting kinase).  We have cloned a novel splice variant of HGK from a human tumor line and have further identified a complex family of HGK splice variants.  We showed HGK to be highly expressed in most tumor cell lines relative to normal tissue.  An active role for this kinase in transformation was suggested by an inhibition of H-RasV12-induced focus formation by expression of inactive, dominant-neg. mutants of HGK in both fibroblast and epithelial cell lines.  Expression of an inactive mutant of HGK also inhibited the anchorage-independent growth of cells yet had no effect on proliferation in monolayer culture.  Expression of HGK mutants modulated integrin receptor expression and had a striking effect on hepatocyte growth factor-stimulated epithelial cell invasion.  Together, these results suggest an important role for HGK in cell transformation and invasiveness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpe0yzhWS2ACbVg90H21EOLACvtfcHk0liHTuGB110BPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvF2isbo%253D&md5=f50bc323f0325d625c4ded384c06102b</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1128%2FMCB.23.6.2068-2082.2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.23.6.2068-2082.2003%26sid%3Dliteratum%253Aachs%26aulast%3DWright%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DManning%26aufirst%3DG.%26aulast%3DLaMere%26aufirst%3DB.%2BJ.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DKhatry%26aufirst%3DD.%26aulast%3DFlanagan%26aufirst%3DP.%2BM.%26aulast%3DBuckley%26aufirst%3DS.%2BD.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DHowlett%26aufirst%3DA.%2BR.%26aulast%3DBischoff%26aufirst%3DJ.%2BR.%26aulast%3DLipson%26aufirst%3DK.%2BE.%26aulast%3DJallal%26aufirst%3DB.%26atitle%3DThe%2520STE20%2520kinse%2520HGK%2520is%2520broadly%2520expressed%2520in%2520human%2520tumor%2520cells%2520and%2520can%2520modulate%2520cellular%2520transformation%252C%2520invasion%252C%2520and%2520adhesion%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2003%26volume%3D23%26spage%3D2068%26epage%3D2082%26doi%3D10.1128%2FMCB.23.6.2068-2082.2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rashid, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abbruzzese, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span> <span> </span><span class="NLM_article-title">Expression of MAP4K4 is associated with worse prognosis in patients with stage II pancreatic ductal adenocarcinoma</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">7043</span>– <span class="NLM_lpage">7049</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-0381</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1158%2F1078-0432.CCR-08-0381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=18981001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlens7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=7043-7049&author=J.+J.+Liangauthor=H.+Wangauthor=A.+Rashidauthor=T.-H.+Tanauthor=R.+F.+Hwangauthor=S.+R.+Hamiltonauthor=J.+L.+Abbruzzeseauthor=D.+B.+Evansauthor=H.+Wang&title=Expression+of+MAP4K4+is+associated+with+worse+prognosis+in+patients+with+stage+II+pancreatic+ductal+adenocarcinoma&doi=10.1158%2F1078-0432.CCR-08-0381"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of MAP4K4 Is Associated with Worse Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma</span></div><div class="casAuthors">Liang, John J.; Wang, Hua; Rashid, Asif; Tan, Tse-Hua; Hwang, Rosa F.; Hamilton, Stanley R.; Abbruzzese, James L.; Evans, Douglas B.; Wang, Huamin</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7043-7049</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: Mitogen-activated protein 4 kinase 4 (MAP4K4) is a serine/threonine kinase and belongs to the mammalian STE20/MAP4K family.  Recent studies have shown that MAP4K4 is overexpressed in many types of human cancer and cancer cell lines.  MAP4K4 plays an important role in transformation, invasiveness, adhesion, and cell migration.  However, the expression of MAP4K4 and its significance in pancreatic ductal adenocarcinoma (PDA) has not been studied.  Exptl. Design: We examd. the expression of MAP4K4 by immunohistochem. using tissue microarrays consisting of 66 stage II PDA and their paired benign pancreatic tissue.  The staining results were categorized as MAP4K4-H or MAP4K4-L.  The results were correlated with clinicopathol. features and patient survival.  RESULTS: MAP4K4 was overexpressed (MAP4K4-H) in 30 of 66 (46%) PDAs and was higher than the paired benign pancreatic tissue samples (19%; P = 0.002).  The median overall and recurrence-free survival for patients with MAP4K4-H PDAs were 19.5 and 9.3 mo, resp., compared with 65.2 and 28.8 mo for patients with MAP4K4-L tumor (P = 0.02 and 0.0005, log-rank test).  MAP4K4 expression was assocd. with poor overall and recurrence-free survival in univariate anal. (P = 0.02 and 0.001).  In multivariate anal., MAP4K4 expression significantly correlated with overall and recurrence-free survival (P = 0.025 and 0.004) independent of age, tumor size, differentiation, and stage.  MAP4K4 expression was also assocd. with higher frequency of recurrence/metastasis, larger tumor size, and increased no. of pos. lymph nodes (P < 0.05).  CONCLUSION: MAP4K4 was overexpressed in about half of PDAs.  Overexpression of MAP4K4 was assocd. with worse prognosis and is a prognostic marker for stage II PDAs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvNmPXk-GGJrVg90H21EOLACvtfcHk0lil3ELYS16rHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlens7fO&md5=5aa75551a71883f256b80f0522849d73</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0381%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DJ.%2BJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRashid%26aufirst%3DA.%26aulast%3DTan%26aufirst%3DT.-H.%26aulast%3DHwang%26aufirst%3DR.%2BF.%26aulast%3DHamilton%26aufirst%3DS.%2BR.%26aulast%3DAbbruzzese%26aufirst%3DJ.%2BL.%26aulast%3DEvans%26aufirst%3DD.%2BB.%26aulast%3DWang%26aufirst%3DH.%26atitle%3DExpression%2520of%2520MAP4K4%2520is%2520associated%2520with%2520worse%2520prognosis%2520in%2520patients%2520with%2520stage%2520II%2520pancreatic%2520ductal%2520adenocarcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D7043%26epage%3D7049%26doi%3D10.1158%2F1078-0432.CCR-08-0381" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bouzakri, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zierath, J. R.</span></span> <span> </span><span class="NLM_article-title">MAP4K4 gene silencing in human skeletal muscle prevents tumor necrosis factor-α-induced insulin resistance</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>282</i></span>,  <span class="NLM_fpage">7783</span>– <span class="NLM_lpage">7789</span>, <span class="refDoi"> DOI: 10.1074/jbc.M608602200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1074%2Fjbc.M608602200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=7783-7789&author=K.+Bouzakriauthor=J.+R.+Zierath&title=MAP4K4+gene+silencing+in+human+skeletal+muscle+prevents+tumor+necrosis+factor-%CE%B1-induced+insulin+resistance&doi=10.1074%2Fjbc.M608602200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M608602200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M608602200%26sid%3Dliteratum%253Aachs%26aulast%3DBouzakri%26aufirst%3DK.%26aulast%3DZierath%26aufirst%3DJ.%2BR.%26atitle%3DMAP4K4%2520gene%2520silencing%2520in%2520human%2520skeletal%2520muscle%2520prevents%2520tumor%2520necrosis%2520factor-%25CE%25B1-induced%2520insulin%2520resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D7783%26epage%3D7789%26doi%3D10.1074%2Fjbc.M608602200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crow, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyczek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastham-Anderson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span> <span> </span><span class="NLM_article-title">MAP4K4 regulates integrin-FERM binding to control endothelial cell motility</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>519</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1038/nature14323</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1038%2Fnature14323" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=2015&pages=425-430&author=P.+Vitorinoauthor=S.+Yeungauthor=A.+Crowauthor=J.+Bakkeauthor=T.+Smyczekauthor=K.+Westauthor=E.+McNamaraauthor=J.+Eastham-Andersonauthor=S.+Gouldauthor=S.+F.+Harrisauthor=C.+Ndubakuauthor=W.+Ye&title=MAP4K4+regulates+integrin-FERM+binding+to+control+endothelial+cell+motility&doi=10.1038%2Fnature14323"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnature14323&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14323%26sid%3Dliteratum%253Aachs%26aulast%3DVitorino%26aufirst%3DP.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DCrow%26aufirst%3DA.%26aulast%3DBakke%26aufirst%3DJ.%26aulast%3DSmyczek%26aufirst%3DT.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DMcNamara%26aufirst%3DE.%26aulast%3DEastham-Anderson%26aufirst%3DJ.%26aulast%3DGould%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DMAP4K4%2520regulates%2520integrin-FERM%2520binding%2520to%2520control%2520endothelial%2520cell%2520motility%26jtitle%3DNature%26date%3D2015%26volume%3D519%26spage%3D425%26epage%3D430%26doi%3D10.1038%2Fnature14323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collins, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapinoso, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micklash, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, P. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hampton, G. M.</span></span> <span> </span><span class="NLM_article-title">A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3775</span>– <span class="NLM_lpage">3780</span>, <span class="refDoi"> DOI: 10.1073/pnas.0600040103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1073%2Fpnas.0600040103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=16537454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD28XivFWis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3775-3780&author=C.+S.+Collinsauthor=J.+Hongauthor=L.+Sapinosoauthor=T.+Zhouauthor=Z.+Liuauthor=K.+Micklashauthor=P.+G.+Schultzauthor=G.+M.+Hampton&title=A+small+interfering+RNA+screen+for+modulators+of+tumor+cell+motility+identifies+MAP4K4+as+a+promigratory+kinase&doi=10.1073%2Fpnas.0600040103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">A small interfering RNA screen for modulators of tumor cell motility identifies MAP4K4 as a promigratory kinase</span></div><div class="casAuthors">Collins, Cynthia S.; Hong, Jiyong; Sapinoso, Lisa; Zhou, Yingyao; Liu, Zheng; Micklash, Kenneth; Schultz, Peter G.; Hampton, Garret M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3775-3780</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cell motility is a complex biol. process, involved in development, inflammation, homeostasis, and pathol. processes such as the invasion and metastatic spread of cancer.  Here, we describe a genomic screen designed to identify inhibitors of cell migration.  A library of 10,996 small interfering RNAs (targeting 5,234 human genes) was screened for their ability to block the migration of a highly motile ovarian carcinoma cell line, SKOV-3, by using a 384-well wound-healing assay coupled with automated microscopy and wound quantification.  Two or more small interfering RNAs against four genes, CDK7, DYRK1B, MAP4K4 (NIK/HGK) (MAP4K4, mitogen-activated protein 4 kinase 4), and SCCA-1 (SerpinB3), potently blocked the migration of SKOV-3 cells, concordant with reduced transcript levels.  Further studies of the promigratory role of MAP4K4 showed that the knockdown of this transcript inhibited the migration of multiple carcinoma cell lines, indicating a broad role in cell motility and potently suppressed the invasion of SKOV-3 cells in vitro.  The effect of MAP4K4 on cellular migration was found to be mediated through c-Jun N-terminal kinase, independent of AP1 activation and downstream transcription.  Accordingly, small mol. inhibition of c-Jun N-terminal kinase suppressed SKOV-3 cell migration, underscoring the potential therapeutic utility of mitogen-activated protein kinase pathway inhibition in cancer progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvNhFFpuIrcbVg90H21EOLACvtfcHk0lil3ELYS16rHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XivFWis7k%253D&md5=19697563ecc7112d4803e2f6ff16ec87</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0600040103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0600040103%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DC.%2BS.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DSapinoso%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DMicklash%26aufirst%3DK.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26aulast%3DHampton%26aufirst%3DG.%2BM.%26atitle%3DA%2520small%2520interfering%2520RNA%2520screen%2520for%2520modulators%2520of%2520tumor%2520cell%2520motility%2520identifies%2520MAP4K4%2520as%2520a%2520promigratory%2520kinase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D3775%26epage%3D3780%26doi%3D10.1073%2Fpnas.0600040103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nehrke, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">The Nck-interacting kinase (NIK) phosphorylate the Na+-H+ exchanger NHE1 and regulates NHE1 activation by platelet-derived growth factor</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">31349</span>– <span class="NLM_lpage">31356</span>, <span class="refDoi"> DOI: 10.1074/jbc.M102679200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1074%2Fjbc.M102679200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=31349-31356&author=W.+Yanauthor=K.+Nehrkeauthor=J.+Choiauthor=D.+L.+Barber&title=The+Nck-interacting+kinase+%28NIK%29+phosphorylate+the+Na%2B-H%2B+exchanger+NHE1+and+regulates+NHE1+activation+by+platelet-derived+growth+factor&doi=10.1074%2Fjbc.M102679200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M102679200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M102679200%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DW.%26aulast%3DNehrke%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Nck-interacting%2520kinase%2520%2528NIK%2529%2520phosphorylate%2520the%2520Na%252B-H%252B%2520exchanger%2520NHE1%2520and%2520regulates%2520NHE1%2520activation%2520by%2520platelet-derived%2520growth%2520factor%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D31349%26epage%3D31356%26doi%3D10.1074%2Fjbc.M102679200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LeClaire, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baumgartner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">The Nck-interacting kinase NIK increases ARP2/3 complex activity by phosphorylating the Arp2 subunit</span>. <i>J. Cell Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>208</i></span>,  <span class="NLM_fpage">161</span>– <span class="NLM_lpage">170</span>, <span class="refDoi"> DOI: 10.1083/jcb.201404095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1083%2Fjcb.201404095" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=208&publication_year=2015&pages=161-170&author=L.+L.+LeClaireauthor=M.+Ranaauthor=M.+Baumgartnerauthor=D.+L.+Barber&title=The+Nck-interacting+kinase+NIK+increases+ARP2%2F3+complex+activity+by+phosphorylating+the+Arp2+subunit&doi=10.1083%2Fjcb.201404095"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201404095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201404095%26sid%3Dliteratum%253Aachs%26aulast%3DLeClaire%26aufirst%3DL.%2BL.%26aulast%3DRana%26aufirst%3DM.%26aulast%3DBaumgartner%26aufirst%3DM.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Nck-interacting%2520kinase%2520NIK%2520increases%2520ARP2%252F3%2520complex%2520activity%2520by%2520phosphorylating%2520the%2520Arp2%2520subunit%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2015%26volume%3D208%26spage%3D161%26epage%3D170%26doi%3D10.1083%2Fjcb.201404095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baumgartner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillman, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackwood, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srivastava, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schilling, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barber, D. L.</span></span> <span> </span><span class="NLM_article-title">The Nck-interacting kinase phosphorylates ERM proteins for formation of lamellipodium by growth factors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">13391</span>– <span class="NLM_lpage">13396</span>, <span class="refDoi"> DOI: 10.1073/pnas.0605950103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1073%2Fpnas.0605950103" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=13391-13396&author=M.+Baumgartnerauthor=A.+L.+Sillmanauthor=E.+M.+Blackwoodauthor=J.+Srivastavaauthor=N.+Madsonauthor=J.+W.+Schillingauthor=J.+H.+Wrightauthor=D.+L.+Barber&title=The+Nck-interacting+kinase+phosphorylates+ERM+proteins+for+formation+of+lamellipodium+by+growth+factors&doi=10.1073%2Fpnas.0605950103"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0605950103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0605950103%26sid%3Dliteratum%253Aachs%26aulast%3DBaumgartner%26aufirst%3DM.%26aulast%3DSillman%26aufirst%3DA.%2BL.%26aulast%3DBlackwood%26aufirst%3DE.%2BM.%26aulast%3DSrivastava%26aufirst%3DJ.%26aulast%3DMadson%26aufirst%3DN.%26aulast%3DSchilling%26aufirst%3DJ.%2BW.%26aulast%3DWright%26aufirst%3DJ.%2BH.%26aulast%3DBarber%26aufirst%3DD.%2BL.%26atitle%3DThe%2520Nck-interacting%2520kinase%2520phosphorylates%2520ERM%2520proteins%2520for%2520formation%2520of%2520lamellipodium%2520by%2520growth%2520factors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D13391%26epage%3D13396%26doi%3D10.1073%2Fpnas.0605950103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwaid, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanyo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geoghegan, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckbinder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carpino, P. A.</span></span> <span> </span><span class="NLM_article-title">MAP4K4 is a threonine kinase that phosphorylates FARP1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2667</span>– <span class="NLM_lpage">2671</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00679</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00679" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=2667-2671&author=A.+G.+Schwaidauthor=C.+Suauthor=P.+Loosauthor=J.+Wuauthor=C.+Nguyenauthor=K.+L.+Stoneauthor=J.+Kanyoauthor=K.+F.+Geogheganauthor=S.+K.+Bhattacharyaauthor=R.+L.+Dowauthor=L.+Buckbinderauthor=P.+A.+Carpino&title=MAP4K4+is+a+threonine+kinase+that+phosphorylates+FARP1&doi=10.1021%2Facschembio.5b00679"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00679%26sid%3Dliteratum%253Aachs%26aulast%3DSchwaid%26aufirst%3DA.%2BG.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DLoos%26aufirst%3DP.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DNguyen%26aufirst%3DC.%26aulast%3DStone%26aufirst%3DK.%2BL.%26aulast%3DKanyo%26aufirst%3DJ.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DCarpino%26aufirst%3DP.%2BA.%26atitle%3DMAP4K4%2520is%2520a%2520threonine%2520kinase%2520that%2520phosphorylates%2520FARP1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2015%26volume%3D10%26spage%3D2667%26epage%3D2671%26doi%3D10.1021%2Facschembio.5b00679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boggs, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drobnick, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jesudason, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sambrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyczek, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitorino, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, W.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of GNE-495, a potent and selective MAP4K4 inhibitor with efficacy in retinal angiogenesis</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">918</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00174</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00174" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVyitLrN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=913-918&author=C.+O.+Ndubakuauthor=T.+D.+Crawfordauthor=H.+Chenauthor=J.+W.+Boggsauthor=J.+Drobnickauthor=S.+F.+Harrisauthor=R.+Jesudasonauthor=E.+McNamaraauthor=J.+Nonomiyaauthor=A.+Sambroneauthor=S.+Schmidtauthor=T.+Smyczekauthor=P.+Vitorinoauthor=L.+Wangauthor=P.+Wuauthor=S.+Yeungauthor=J.+Chenauthor=K.+Chenauthor=C.+Z.+Dingauthor=T.+Wangauthor=Z.+Xuauthor=S.+E.+Gouldauthor=L.+J.+Murrayauthor=W.+Ye&title=Structure-based+design+of+GNE-495%2C+a+potent+and+selective+MAP4K4+inhibitor+with+efficacy+in+retinal+angiogenesis&doi=10.1021%2Facsmedchemlett.5b00174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of GNE-495, a Potent and Selective MAP4K4 Inhibitor with Efficacy in Retinal Angiogenesis</span></div><div class="casAuthors">Ndubaku, Chudi O.; Crawford, Terry D.; Chen, Huifen; Boggs, Jason W.; Drobnick, Joy; Harris, Seth F.; Jesudason, Rajiv; McNamara, Erin; Nonomiya, Jim; Sambrone, Amy; Schmidt, Stephen; Smyczek, Tanya; Vitorino, Philip; Wang, Lan; Wu, Ping; Yeung, Stacey; Chen, Jinhua; Chen, Kevin; Ding, Charles Z.; Wang, Tao; Xu, Zijin; Gould, Stephen E.; Murray, Lesley J.; Ye, Weilan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">913-918</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Diverse biol. roles for mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) have necessitated the identification of potent inhibitors to study its function in various disease contexts.  In particular, compds. that can be used to carry out such studies in vivo would be crit. for elucidating the potential for therapeutic intervention.  A structure-based design effort coupled with property-guided optimization directed at minimizing the ability of the inhibitors to cross into the CNS led to an advanced compd. (I; GNE-495) that showed excellent potency and good PK and was used to demonstrate in vivo efficacy in a retinal angiogenesis model recapitulating effects that were obsd. in the inducible Map4k4 knockout mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7caqOoftyhLVg90H21EOLACvtfcHk0ljHS79nej1VDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVyitLrN&md5=fbda60a194fb2b4fb73f0e16dd8438e8</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00174%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%2BO.%26aulast%3DCrawford%26aufirst%3DT.%2BD.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DBoggs%26aufirst%3DJ.%2BW.%26aulast%3DDrobnick%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DJesudason%26aufirst%3DR.%26aulast%3DMcNamara%26aufirst%3DE.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DSambrone%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DS.%26aulast%3DSmyczek%26aufirst%3DT.%26aulast%3DVitorino%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DP.%26aulast%3DYeung%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DMurray%26aufirst%3DL.%2BJ.%26aulast%3DYe%26aufirst%3DW.%26atitle%3DStructure-based%2520design%2520of%2520GNE-495%252C%2520a%2520potent%2520and%2520selective%2520MAP4K4%2520inhibitor%2520with%2520efficacy%2520in%2520retinal%2520angiogenesis%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D913%26epage%3D918%26doi%3D10.1021%2Facsmedchemlett.5b00174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammirati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagley, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckbinder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlo, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cortes, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dow, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimarães, C. R.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaPerle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Londregan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loria, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathiowetz, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skoura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of an in vivo tool to establish proof-of-concept for MAP4K4-based antidiabetic treatment</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1133</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00215</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1128-1133&author=M.+Ammiratiauthor=S.+W.+Bagleyauthor=S.+K.+Bhattacharyaauthor=L.+Buckbinderauthor=A.+A.+Carloauthor=R.+Conradauthor=C.+Cortesauthor=R.+L.+Dowauthor=M.+S.+Dowlingauthor=A.+El-Kattanauthor=K.+Fordauthor=C.+R.%0AW.+Guimar%C3%A3esauthor=D.+Hepworthauthor=W.+Jiaoauthor=J.+LaPerleauthor=S.+Liuauthor=A.+Londreganauthor=P.+M.+Loriaauthor=A.+M.+Mathiowetzauthor=M.+Munchhofauthor=S.+T.+M.+Orrauthor=D.+N.+Petersenauthor=D.+A.+Priceauthor=A.+Skouraauthor=A.+C.+Smithauthor=J.+Wang&title=Discovery+of+an+in+vivo+tool+to+establish+proof-of-concept+for+MAP4K4-based+antidiabetic+treatment&doi=10.1021%2Facsmedchemlett.5b00215"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00215%26sid%3Dliteratum%253Aachs%26aulast%3DAmmirati%26aufirst%3DM.%26aulast%3DBagley%26aufirst%3DS.%2BW.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBuckbinder%26aufirst%3DL.%26aulast%3DCarlo%26aufirst%3DA.%2BA.%26aulast%3DConrad%26aufirst%3DR.%26aulast%3DCortes%26aufirst%3DC.%26aulast%3DDow%26aufirst%3DR.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEl-Kattan%26aufirst%3DA.%26aulast%3DFord%26aufirst%3DK.%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DJiao%26aufirst%3DW.%26aulast%3DLaPerle%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DLondregan%26aufirst%3DA.%26aulast%3DLoria%26aufirst%3DP.%2BM.%26aulast%3DMathiowetz%26aufirst%3DA.%2BM.%26aulast%3DMunchhof%26aufirst%3DM.%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DPetersen%26aufirst%3DD.%2BN.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DSkoura%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520in%2520vivo%2520tool%2520to%2520establish%2520proof-of-concept%2520for%2520MAP4K4-based%2520antidiabetic%2520treatment%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1128%26epage%3D1133%26doi%3D10.1021%2Facsmedchemlett.5b00215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Förster, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richters, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ziegler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rauh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldmann, H.</span></span> <span> </span><span class="NLM_article-title">Neuritogenic militarinone-inspired 4-hydroxypyridones target the stress pathway kinase MAP4K4</span>. <i>Angew. Chem., Int. Ed.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">12398</span>– <span class="NLM_lpage">12403</span>, <span class="refDoi"> DOI: 10.1002/anie.201501515</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1002%2Fanie.201501515" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2015&pages=12398-12403&author=P.+Schr%C3%B6derauthor=T.+F%C3%B6rsterauthor=S.+Kleineauthor=C.+Beckerauthor=A.+Richtersauthor=S.+Zieglerauthor=D.+Rauhauthor=K.+Kumarauthor=H.+Waldmann&title=Neuritogenic+militarinone-inspired+4-hydroxypyridones+target+the+stress+pathway+kinase+MAP4K4&doi=10.1002%2Fanie.201501515"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1002%2Fanie.201501515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.201501515%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DP.%26aulast%3DF%25C3%25B6rster%26aufirst%3DT.%26aulast%3DKleine%26aufirst%3DS.%26aulast%3DBecker%26aufirst%3DC.%26aulast%3DRichters%26aufirst%3DA.%26aulast%3DZiegler%26aufirst%3DS.%26aulast%3DRauh%26aufirst%3DD.%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DWaldmann%26aufirst%3DH.%26atitle%3DNeuritogenic%2520militarinone-inspired%25204-hydroxypyridones%2520target%2520the%2520stress%2520pathway%2520kinase%2520MAP4K4%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2015%26volume%3D54%26spage%3D12398%26epage%3D12403%26doi%3D10.1002%2Fanie.201501515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guimarães, C. R.
W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rai, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munchhof, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckbinder, L.</span></span> <span> </span><span class="NLM_article-title">Understanding the impact of the P-loop conformation on kinase selectivity</span>. <i>J. Chem. Inf. Model.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1199</span>– <span class="NLM_lpage">1204</span>, <span class="refDoi"> DOI: 10.1021/ci200153c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200153c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1199-1204&author=C.+R.%0AW.+Guimar%C3%A3esauthor=B.+K.+Raiauthor=M.+J.+Munchhofauthor=S.+Liuauthor=J.+Wangauthor=S.+K.+Bhattacharyaauthor=L.+Buckbinder&title=Understanding+the+impact+of+the+P-loop+conformation+on+kinase+selectivity&doi=10.1021%2Fci200153c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the impact of the P-loop conformation on kinase selectivity</span></div><div class="casAuthors">Guimaraes, Cristiano R. W.; Rai, Brajesh K.; Munchhof, Michael J.; Liu, Shenping; Wang, Jian; Bhattacharya, Samit K.; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1199-1204</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work addresses the link between selectivity and an unusual, folded conformation for the P-loop obsd. initially for MAP4K4 kinase and subsequently for other kinases.  Statistical and computational analyses of the authors' crystal structure database demonstrated that inhibitors that induced the P-loop folded conformation tended to be more selective, esp. if they took advantage of this specific conformation by interacting more favorably with a conserved Tyr or Phe residue from the P-loop.  The role of the P-loop in the crystal structures of MAP4K4 kinase and 2 selective inhibitors was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofyL-cXXqwPLVg90H21EOLACvtfcHk0lhZd0PgNf8WIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D&md5=3179e5f43bf2534badc595dced50d8c4</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fci200153c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200153c%26sid%3Dliteratum%253Aachs%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DRai%26aufirst%3DB.%2BK.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DUnderstanding%2520the%2520impact%2520of%2520the%2520P-loop%2520conformation%2520on%2520kinase%2520selectivity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26spage%3D1199%26epage%3D1204%26doi%3D10.1021%2Fci200153c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aouadi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tesz, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicoloro, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chouinard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ostroff, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czech, M. P.</span></span> <span> </span><span class="NLM_article-title">Orally delivered siRNA targeting macrophage MAP4K4 suppresses systemic inflammation</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>458</i></span>,  <span class="NLM_fpage">1180</span>– <span class="NLM_lpage">1184</span>, <span class="refDoi"> DOI: 10.1038/nature07774</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1038%2Fnature07774" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=19407801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=458&publication_year=2009&pages=1180-1184&author=M.+Aouadiauthor=G.+J.+Teszauthor=S.+M.+Nicoloroauthor=M.+Wangauthor=M.+Chouinardauthor=E.+Sotoauthor=G.+R.+Ostroffauthor=M.+P.+Czech&title=Orally+delivered+siRNA+targeting+macrophage+MAP4K4+suppresses+systemic+inflammation&doi=10.1038%2Fnature07774"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation</span></div><div class="casAuthors">Aouadi, Myriam; Tesz, Gregory J.; Nicoloro, Sarah M.; Wang, Mengxi; Chouinard, My; Soto, Ernesto; Ostroff, Gary R.; Czech, Michael P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">458</span>
        (<span class="NLM_cas:issue">7242</span>),
    <span class="NLM_cas:pages">1180-1184</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Gene silencing by double-stranded RNA, denoted RNA interference, represents a new paradigm for rational drug design.  However, the transformative therapeutic potential of short interfering RNA (siRNA) has been stymied by a key obstacle-safe delivery to specified target cells in vivo.  Macrophages are particularly attractive targets for RNA interference therapy because they promote pathogenic inflammatory responses in diseases such as rheumatoid arthritis, atherosclerosis, inflammatory bowel disease and diabetes.  Here we report the engineering of β1,3-D-glucan-encapsulated siRNA particles (GeRPs) as efficient oral delivery vehicles that potently silence genes in mouse macrophages in vitro and in vivo.  Oral gavage of mice with GeRPs contg. as little as 20 μg kg-1 siRNA directed against tumor necrosis factor α (Tnf-α) depleted its mRNA in macrophages recovered from the peritoneum, spleen, liver and lung, and lowered serum Tnf-α levels.  Screening with GeRPs for inflammation genes revealed that the mitogen-activated protein kinase kinase kinase kinase 4 (Map4k4) is a previously unknown mediator of cytokine expression.  Importantly, silencing Map4k4 in macrophages in vivo protected mice from lipopolysaccharide-induced lethality by inhibiting Tnf-α and interleukin-1β prodn.  This technol. defines a new strategy for oral delivery of siRNA to attenuate inflammatory responses in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoicgkm9195HLVg90H21EOLACvtfcHk0lhZd0PgNf8WIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXlt1Sku7o%253D&md5=708368d17ae943b509affc54a156ac7f</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnature07774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature07774%26sid%3Dliteratum%253Aachs%26aulast%3DAouadi%26aufirst%3DM.%26aulast%3DTesz%26aufirst%3DG.%2BJ.%26aulast%3DNicoloro%26aufirst%3DS.%2BM.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DChouinard%26aufirst%3DM.%26aulast%3DSoto%26aufirst%3DE.%26aulast%3DOstroff%26aufirst%3DG.%2BR.%26aulast%3DCzech%26aufirst%3DM.%2BP.%26atitle%3DOrally%2520delivered%2520siRNA%2520targeting%2520macrophage%2520MAP4K4%2520suppresses%2520systemic%2520inflammation%26jtitle%3DNature%26date%3D2009%26volume%3D458%26spage%3D1180%26epage%3D1184%26doi%3D10.1038%2Fnature07774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">Unpublished results on MAP4K4 enzymatic/TDI profiling of ∼60 analogues from this chemical series.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morganroth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, D. R.</span></span> <span> </span><span class="NLM_article-title">Cardiovascular safety of tyrosine kinase inhibitors: with a special focus on cardiac repolarisation (QT interval)</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">316</span>, <span class="refDoi"> DOI: 10.1007/s40264-013-0047-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1007%2Fs40264-013-0047-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=23620167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=295-316&author=R.+R.+Shahauthor=J.+Morganrothauthor=D.+R.+Shah&title=Cardiovascular+safety+of+tyrosine+kinase+inhibitors%3A+with+a+special+focus+on+cardiac+repolarisation+%28QT+interval%29&doi=10.1007%2Fs40264-013-0047-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on Cardiac Repolarisation (QT Interval)</span></div><div class="casAuthors">Shah, Rashmi R.; Morganroth, Joel; Shah, Devron R.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">295-316</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">A review.  The development of tyrosine kinase inhibitors (TKI) represents a major milestone in oncol.  However, their use has been found to be assocd. with serious toxicities that impinge on various vital organs including the heart.  Sixteen TKIs have been approved for use in oncol. as of 30 Sept. 2012, and a large no. of others are in development or under regulatory review.  Cardiovascular safety of medicinal products is a major public health issue that has concerned all the stakeholders.  This review focuses on three specific cardiovascular safety aspects of TKIs, namely their propensity to induce QT interval prolongation, left ventricular (LV) dysfunction and hypertension (both systemic and pulmonary).  Analyses of information in drug labels, the data submitted to the regulatory authorities and the published literature show that a no. of TKIs are assocd. with these undesirable effects.  Whereas LV dysfunction and systemic hypertension are on-target effects related to the inhibition of ligand-related signalling pathways, QT interval prolongation appears to be an off-target class III electrophysiol. effect, possibly related to the presence of a fluorine-based pharmacophore.  If not adequately managed, these cardiovascular effects significantly increase the morbidity and mortality in a population already at high risk.  Hitherto, the QT effect of most QT-prolonging TKIs (except lapatinib, nilotinib, sunitinib and vandetanib) is relatively mild at clin. doses and has not led to appreciable morbidity clin.  In contrast, LV dysfunction and untreated hypertension have resulted in significant morbidity.  Inevitably, dilemmas arise in detg. the risk/benefit of a TKI therapy in an individual patient who develops any of these effects following the treatment of the TKI-sensitive cancer.  QT interval prolongation, hypertension and LV dysfunction can be managed effectively by using reliable methods of measurement and careful monitoring of patients whose clin. management requires optimization by a close collaboration between an oncologist and a cardiologist, an evolving subspecialty referred to as cardio-oncol.  Despite their potential adverse clin. impact, the effects of TKIs on hypertension and LV function are generally inadequately characterised during their development.  As has been the case with QT liability of drugs, there is now a persuasive case for a regulatory requirement to study TKIs systematically for these effects.  Furthermore, since most of these novel drugs are studied in trials with relatively small sample sizes and approved on an expedited basis, there is also a compelling case for their effective pharmacovigilance and on-going reassessment of their risk/benefit after approval.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgTIlxLItaUbVg90H21EOLACvtfcHk0lihxrUxwE072w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsl2nsL3L&md5=7e24ea72e614d9b85a87dbc88a973c58</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs40264-013-0047-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40264-013-0047-5%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DR.%2BR.%26aulast%3DMorganroth%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DD.%2BR.%26atitle%3DCardiovascular%2520safety%2520of%2520tyrosine%2520kinase%2520inhibitors%253A%2520with%2520a%2520special%2520focus%2520on%2520cardiac%2520repolarisation%2520%2528QT%2520interval%2529%26jtitle%3DDrug%2520Saf.%26date%3D2013%26volume%3D36%26spage%3D295%26epage%3D316%26doi%3D10.1007%2Fs40264-013-0047-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">Percent change in midazolam metabolism by CYP3A4 at 60, 30, 10, 3, and 1 μM test compound concentrations: 61, 54, 27, 14, and 16% for <b>1</b> and 3, 4, −1, −4, and −4% for <b>5</b>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">Apparent, intrinsic human liver microsomal clearance values for <b>1</b> and <b>3</b>–<b>5</b> of 42, <8, <8, and 14 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitney-Pickett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Umland, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gebhard, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Federico, J. J.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davidson, R. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyner, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varma, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempshall, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Kattan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liston, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span> <span> </span><span class="NLM_article-title">Development of a new permeability assay using low-efflux MDCKII cells</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">4974</span>– <span class="NLM_lpage">4985</span>, <span class="refDoi"> DOI: 10.1002/jps.22674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1002%2Fjps.22674" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=21766308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2011&pages=4974-4985&author=L.+Diauthor=C.+Whitney-Pickettauthor=J.+P.+Umlandauthor=H.+Zhangauthor=X.+Zhangauthor=D.+F.+Gebhardauthor=Y.+Laiauthor=J.+J.+Federicoauthor=R.+F.+Davidsonauthor=R.+Smithauthor=E.+L.+Reynerauthor=C.+Leeauthor=B.+Fengauthor=C.+Rotterauthor=M.+V.+Varmaauthor=S.+Kempshallauthor=K.+Fennerauthor=A.+F.+El-Kattanauthor=T.+E.+Listonauthor=M.+D.+Troutman&title=Development+of+a+new+permeability+assay+using+low-efflux+MDCKII+cells&doi=10.1002%2Fjps.22674"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new permeability assay using low-efflux MDCKII cells</span></div><div class="casAuthors">Di, Li; Whitney-Pickett, Carrie; Umland, John P.; Zhang, Hui; Zhang, Xun; Gebhard, David F.; Lai, Yurong; Federico, James J.; Davidson, Ralph E.; Smith, Russ; Reyner, Eric L.; Lee, Caroline; Feng, Bo; Rotter, Charles; Varma, Manthena V.; Kempshall, Sarah; Fenner, Katherine; El-kattan, Ayman F.; Liston, Theodore E.; Troutman, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4974-4985</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Permeability is an important property of drug candidates.  The Madin-Darby canine kidney cell line (MDCK) permeability assay is widely used and the primary concern of using MDCK cells is the presence of endogenous transporters of nonhuman origin.  The canine P-glycoprotein (Pgp) can interfere with permeability and transporter studies, leading to less reliable data.  A new cell line, MDCKII-LE (low efflux), has been developed by selecting a subpopulation of low-efflux cells from MDCKII-WT using an iterative fluorescence-activated cell sorting technique with calcein-AM as a Pgp and efflux substrate.  MDCKII-LE cells are a subpopulation of MDCKII cells with over 200-fold lower canine Pgp mRNA level and fivefold lower protein level than MDCKII-WT.  MDCKII-LE cells showed less functional efflux activity than MDCKII-WT based on efflux ratios.  Notably, MDCKII-MDR1 showed about 1.5-fold decreased expression of endogenous canine Pgp, suggesting that using the net flux ratio might not completely cancel out the background endogenous transporter activities.  MDCKII-LE cells offer clear advantages over the MDCKII-WT by providing less efflux transporter background signals and minimizing interference from canine Pgp.  The MDCKII-LE apparent permeability values well differentiates compds. from high to medium/low human intestinal absorption and can be used for Biopharmaceutical Classification System.  The MDCKII-LE permeability assay (4-in-1 cassette dosing) is high throughput with good precision, reproducibility, robustness, and cost-effective. © 2011 Wiley-Liss, Inc. and the American Pharmacists Assocn. J Pharm Sci.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTVtRmYnbF17Vg90H21EOLACvtfcHk0lihxrUxwE072w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXovFGltb8%253D&md5=97f647fc215ea6d04882351ffc912a1e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1002%2Fjps.22674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.22674%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26aulast%3DWhitney-Pickett%26aufirst%3DC.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DGebhard%26aufirst%3DD.%2BF.%26aulast%3DLai%26aufirst%3DY.%26aulast%3DFederico%26aufirst%3DJ.%2BJ.%26aulast%3DDavidson%26aufirst%3DR.%2BF.%26aulast%3DSmith%26aufirst%3DR.%26aulast%3DReyner%26aufirst%3DE.%2BL.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DRotter%26aufirst%3DC.%26aulast%3DVarma%26aufirst%3DM.%2BV.%26aulast%3DKempshall%26aufirst%3DS.%26aulast%3DFenner%26aufirst%3DK.%26aulast%3DEl-Kattan%26aufirst%3DA.%2BF.%26aulast%3DListon%26aufirst%3DT.%2BE.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520permeability%2520assay%2520using%2520low-efflux%2520MDCKII%2520cells%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2011%26volume%3D100%26spage%3D4974%26epage%3D4985%26doi%3D10.1002%2Fjps.22674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">Given their high degree of ATP-site homology, members of this aminopyridine series also inhibit the other GCK family members (ZC2, TNIK, and ZC3, MINK) to a degree similar to that of MAP4K4.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripp, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henderson, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span> <span> </span><span class="NLM_article-title">Mechanism-based inactivation (MBI) of cytochrome P450 enzymes: structure–activity relationships and discovery strategies to mitigate drug–drug interaction risks</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4896</span>– <span class="NLM_lpage">4933</span>, <span class="refDoi"> DOI: 10.1021/jm300065h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300065h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4896-4933&author=S.+T.+Orrauthor=S.+L.+Rippauthor=T.+E.+Ballardauthor=J.+L.+Hendersonauthor=D.+O.+Scottauthor=R.+S.+Obachauthor=H.+Sunauthor=A.+S.+Kalgutkar&title=Mechanism-based+inactivation+%28MBI%29+of+cytochrome+P450+enzymes%3A+structure%E2%80%93activity+relationships+and+discovery+strategies+to+mitigate+drug%E2%80%93drug+interaction+risks&doi=10.1021%2Fjm300065h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism-Based Inactivation (MBI) of Cytochrome P450 Enzymes: Structure-Activity Relationships and Discovery Strategies To Mitigate Drug-Drug Interaction Risks</span></div><div class="casAuthors">Orr, Suvi T. M.; Ripp, Sharon L.; Ballard, T. Eric; Henderson, Jaclyn L.; Scott, Dennis O.; Obach, R. Scott; Sun, Hao; Kalgutkar, Amit S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4896-4933</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The importance of mitigating drug-drug interaction (DDI) risks, which arise from inhibition of major human cytochrome P 450 enzymes is a well-established component of the lead optimization process in drug discovery.  More recently, there has been much interest in clin. DDIs potentially arising via time- and concn.-dependent cytochrome P 450 inhibition, a phenomenon consistent with mechanism-based inactivation.  Inactivated P 450 is catalytically incompetent and must be replenished by newly synthesized protein.  Consequently, time-dependent inhibition of P450s presents a greater safety concern compared to reversible inhibition because of the increased propensity for pharmacokinetic interactions upon multiple dosing and the sustained duration of these interactions after discontinuation of the mechanism-based inactivator.  Mechanism-based or time-dependent P 450 inhibitors pose an addnl. risk of idiosyncratic drug toxicity since the mechanism of time-dependency often involves the formation of reactive metabolites, which can react with proteins other than the P 450 isoenzyme responsible for catalysis. in vitro time-dependent inhibition (TDI) of P 450 enzymes is now routinely assessed as part of lead optimization efforts in preclin. drug discovery.  However, identification of an in vitro TDI liability can raise several questions such as: What is the mechanism of TDI.  Does it involve the formation of reactive metabolites.  Is there a 1:1 correlation between P 450 TDI and RM formation (as measured from reactive metabolite trapping studies).  What is the likelihood that a P 450 time-dependent inhibitor will also cause toxicity.  What are the DDI risk mitigation options when dealing with P 450 inactivators in drug discovery - compd. progression or termination.  Several drugs exhibit in vitro TDI of P 450 enzymes, but only a fraction thereof causes clin. DDIs.  Hence, when do we initiate labor-intensive medicinal chem. efforts to design compds. devoid of P 450 TDI liability.  What are the best methods to precisely predict the likelihood of occurrence of clin. DDIs with drug candidates that inactivate P 450 enzymes.  What are (if any) the qualifying considerations for clin. progression of a P 450 time-dependent inactivator with projected clin. DDI risks.  In an effort to address these questions and hopefully provide answers to some of them, we embarked on the present venture wherein we highlight the current state-of-the-art knowledge in this field with a special emphasis on (a) available biochem. and mechanistic approaches in drug discovery to examine TDI of P 450 isoenzymes with new chem. entities, (b) structure-activity relationship studies with marketed drugs assocd. with DDIs via P 450 inactivation, (c) case studies of medicinal chem. tactics to abrogate P 450 inactivation liability, (d) strategies for progression of P 450 TDI-pos. drug candidates, and (e) the utility of in silico methodol., including the use of physiol.-based pharmacokinetic simulators, in drug discovery to predict the magnitude of clin. DDIs risks anticipated with new clin. candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDO60qqRvpS7Vg90H21EOLACvtfcHk0lihxrUxwE072w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjs1Wlur8%253D&md5=aa4aa4f633b3b4f73b3d79917327b0de</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm300065h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300065h%26sid%3Dliteratum%253Aachs%26aulast%3DOrr%26aufirst%3DS.%2BT.%26aulast%3DRipp%26aufirst%3DS.%2BL.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DHenderson%26aufirst%3DJ.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BO.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26atitle%3DMechanism-based%2520inactivation%2520%2528MBI%2529%2520of%2520cytochrome%2520P450%2520enzymes%253A%2520structure%25E2%2580%2593activity%2520relationships%2520and%2520discovery%2520strategies%2520to%2520mitigate%2520drug%25E2%2580%2593drug%2520interaction%2520risks%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4896%26epage%3D4933%26doi%3D10.1021%2Fjm300065h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benbow, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aleo, M. D.</span></span> <span> </span><span class="NLM_article-title">Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studies</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">175</span>– <span class="NLM_lpage">182</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2010.05.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1016%2Fj.toxlet.2010.05.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=20576494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVagu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2010&pages=175-182&author=J.+W.+Benbowauthor=J.+Aubrechtauthor=M.+J.+Bankerauthor=D.+Nettletonauthor=M.+D.+Aleo&title=Predicting+safety+toleration+of+pharmaceutical+chemical+leads%3A+cytotoxicity+correlations+to+exploratory+toxicity+studies&doi=10.1016%2Fj.toxlet.2010.05.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies</span></div><div class="casAuthors">Benbow, John W.; Aubrecht, Jiri; Banker, Michael J.; Nettleton, David; Aleo, Michael D.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">175-182</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The selection and application of appropriate safety screening paradigms could revolutionize the drug discovery process by reducing safety-related attrition.  While mechanism specific genotoxicity and safety pharmacol. assays are routinely used in screening, the overall value of employing nonspecific cytotoxicity assays remains controversial.  A retrospective anal. of safety findings from rat exploratory toxicity studies (4-14 days) utilizing compds. that spanned broad therapeutic targets (protease, transport, G-protein-coupled receptors, and kinase inhibitors, cGMP modulators) demonstrated that safety toleration in vivo could be approximated using cytotoxicity values.  A composite safety score was calcd. for each compd. dose based on findings in each of the following categories: systemic toleration (mortality, food consumption, and adverse clin. signs), clin. chem./hematol. parameters (deviations from normal ranges), and multiorgan pathol. (necrosis or incidence/severity of histol. change).  Binning compds. into potent (LC50 < 10 μM) and non-potent (LC50 > 100 μM) cytotoxicants in vitro showed that compared to non-potent cytotoxicants the exposure to potent cytotoxicants in vivo resulted in higher overall severity scores at lower exposures.  Correlating overall toleration for individual compds. was further refined when in vivo exposure was considered.  When av. plasma exposure (Cpave) for a compd. exceeded its mean lethal concn. (LC50) in vitro (Cpave/LC50 > 1), higher overall severity scores were achieved compared to lower exposure margins (Cpave/LC50 <0.01).  Based on this anal., the ability to select lead series and individual compds. with better safety characteristics is presented.  In summary, cytotoxicity screening can be used to approx., not define, the safety characteristics of lead pharmaceutical series early in the drug discovery process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUhD17guOBELVg90H21EOLACvtfcHk0liTAIMfXQxdUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVagu7s%253D&md5=0740fad66ffc69226d1e9971fab41ef5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2010.05.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2010.05.016%26sid%3Dliteratum%253Aachs%26aulast%3DBenbow%26aufirst%3DJ.%2BW.%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DBanker%26aufirst%3DM.%2BJ.%26aulast%3DNettleton%26aufirst%3DD.%26aulast%3DAleo%26aufirst%3DM.%2BD.%26atitle%3DPredicting%2520safety%2520toleration%2520of%2520pharmaceutical%2520chemical%2520leads%253A%2520cytotoxicity%2520correlations%2520to%2520exploratory%2520toxicity%2520studies%26jtitle%3DToxicol.%2520Lett.%26date%3D2010%26volume%3D197%26spage%3D175%26epage%3D182%26doi%3D10.1016%2Fj.toxlet.2010.05.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aubrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osowski, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persaud, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackerman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopes, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ku, W. W.</span></span> <span> </span><span class="NLM_article-title">Bioluminescent Salmonella reverse mutation assay: a screen for detecting mutagenicity with high throughput attributes</span>. <i>Mutagenesis</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">342</span>, <span class="refDoi"> DOI: 10.1093/mutage/gem022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1093%2Fmutage%2Fgem022" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2007&pages=335-342&author=J.+Aubrechtauthor=J.+J.+Osowskiauthor=P.+Persaudauthor=J.+R.+Cheungauthor=J.+Ackermanauthor=S.+H.+Lopesauthor=W.+W.+Ku&title=Bioluminescent+Salmonella+reverse+mutation+assay%3A+a+screen+for+detecting+mutagenicity+with+high+throughput+attributes&doi=10.1093%2Fmutage%2Fgem022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1093%2Fmutage%2Fgem022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fmutage%252Fgem022%26sid%3Dliteratum%253Aachs%26aulast%3DAubrecht%26aufirst%3DJ.%26aulast%3DOsowski%26aufirst%3DJ.%2BJ.%26aulast%3DPersaud%26aufirst%3DP.%26aulast%3DCheung%26aufirst%3DJ.%2BR.%26aulast%3DAckerman%26aufirst%3DJ.%26aulast%3DLopes%26aufirst%3DS.%2BH.%26aulast%3DKu%26aufirst%3DW.%2BW.%26atitle%3DBioluminescent%2520Salmonella%2520reverse%2520mutation%2520assay%253A%2520a%2520screen%2520for%2520detecting%2520mutagenicity%2520with%2520high%2520throughput%2520attributes%26jtitle%3DMutagenesis%26date%3D2007%26volume%3D22%26spage%3D335%26epage%3D342%26doi%3D10.1093%2Fmutage%2Fgem022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="note"><p class="first last">Following completion of our work, there was a report of an alternative approach to peripherally restricted MAP4K4 inhibitors (ref <a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a>).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span> <span> </span><span class="NLM_article-title">In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2012</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1124%2Fdmd.113.053868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=24009309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2012-2017&author=R.+Kikuchiauthor=S.+M.+de+Moraisauthor=J.+C.+Kalvass&title=In+vitro+P-glycoprotein+efflux+ratio+can+predict+the+in+vivo+brain+penetration+regardless+of+biopharmaceutics+drug+disposition+classification+system+class&doi=10.1124%2Fdmd.113.053868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class</span></div><div class="casAuthors">Kikuchi, Ryota; de Morais, Sonia M.; Kalvass, J. Cory</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2012-2017</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) is expressed at the blood-brain barrier (BBB) and restricts the penetration of its substrates into the central nervous system (CNS).  In vitro substrate assessment for P-gp is frequently used to predict the in vivo relevance of P-gp-mediated efflux at the BBB.  We have conducted a comprehensive review of literature focusing on the in vitro-in vivo correlation of P-gp efflux ratio (ER), and demonstrated that in vitro substrates of P-gp are also in vivo substrates at the BBB.  It was of note that the in vitro ER in the MDCK-MDR1 cell line from National Institutes of Health was found to be a better predictor of in vivo ER than that from Netherlands Cancer Institute, with r2 values of 0.813 and 0.531, resp.  Recently, a research group proposed that 98% of Biopharmaceutics Drug Disposition Classification System (BDDCS) class 1 drugs can penetrate the brain even when those compds. are shown as P-gp substrates in vitro.  However, our data anal. suggested that in vitro ER can predict the in vivo brain penetration regardless of the class in BDDCS.  Considering that very few marketed CNS drugs are in vivo substrates for P-gp, the in vitro substrate assessment of P-gp should be used in the early stages of drug discovery to select compds. that are most likely to penetrate the CNS to exert their pharmacol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFQtEu5USc2LVg90H21EOLACvtfcHk0liTAIMfXQxdUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO&md5=f4e32455375b1bd684ba38174a71657c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053868%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520efflux%2520ratio%2520can%2520predict%2520the%2520in%2520vivo%2520brain%2520penetration%2520regardless%2520of%2520biopharmaceutics%2520drug%2520disposition%2520classification%2520system%2520class%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D2012%26epage%3D2017%26doi%3D10.1124%2Fdmd.113.053868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelesky, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troutman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, B.</span></span> <span> </span><span class="NLM_article-title">The effect of breast cancer resistance protein and P-glycoprotein on the brain penetration of flavopiridol, imatinib mesylate (gleevac), prazosin, and 2-methoxy-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid (PF-0407288) in mice</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">946</span>– <span class="NLM_lpage">955</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.024489</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=10.1124%2Fdmd.108.024489" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=946-955&author=L.+Zhouauthor=K.+Schmidtauthor=F.+R.+Nelsonauthor=V.+Zeleskyauthor=M.+D.+Troutmanauthor=B.+Feng&title=The+effect+of+breast+cancer+resistance+protein+and+P-glycoprotein+on+the+brain+penetration+of+flavopiridol%2C+imatinib+mesylate+%28gleevac%29%2C+prazosin%2C+and+2-methoxy-3-%284-%282-%285-methyl-2-phenyloxazol-4-yl%29ethoxy%29phenyl%29propanoic+acid+%28PF-0407288%29+in+mice&doi=10.1124%2Fdmd.108.024489"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.024489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.024489%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DSchmidt%26aufirst%3DK.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DZelesky%26aufirst%3DV.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DFeng%26aufirst%3DB.%26atitle%3DThe%2520effect%2520of%2520breast%2520cancer%2520resistance%2520protein%2520and%2520P-glycoprotein%2520on%2520the%2520brain%2520penetration%2520of%2520flavopiridol%252C%2520imatinib%2520mesylate%2520%2528gleevac%2529%252C%2520prazosin%252C%2520and%25202-methoxy-3-%25284-%25282-%25285-methyl-2-phenyloxazol-4-yl%2529ethoxy%2529phenyl%2529propanoic%2520acid%2520%2528PF-0407288%2529%2520in%2520mice%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D946%26epage%3D955%26doi%3D10.1124%2Fdmd.108.024489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miyaura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, A.</span></span> <span> </span><span class="NLM_article-title">Palladium-catalyzed cross-coupling reactions of organoboron compounds</span>. <i>Chem. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>95</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">2457</span>– <span class="NLM_lpage">2483</span>, <span class="refDoi"> DOI: 10.1021/cr00039a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr00039a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;key=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1995&pages=2457-2483&issue=7&author=N.+Miyauraauthor=A.+Suzuki&title=Palladium-catalyzed+cross-coupling+reactions+of+organoboron+compounds&doi=10.1021%2Fcr00039a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds</span></div><div class="casAuthors">Miyaura, Norio; Suzuki, Akira</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2457-83</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with >250 refs. including title reactions and their mechanisms, prepn. of organoboron reagents, alkoxycarbonylation and dimerization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwupBJT1UCbVg90H21EOLACvtfcHk0lj4OYkQwWUH9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXoslGiurg%253D&md5=d127b414a75161652876eebc3ed0c486</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcr00039a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00039a007%26sid%3Dliteratum%253Aachs%26aulast%3DMiyaura%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DA.%26atitle%3DPalladium-catalyzed%2520cross-coupling%2520reactions%2520of%2520organoboron%2520compounds%26jtitle%3DChem.%2520Rev.%26date%3D1995%26volume%3D95%26issue%3D7%26spage%3D2457%26epage%3D2483%26doi%3D10.1021%2Fcr00039a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95','PDB','5J95'); return false;">PDB: 5J95</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i26"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00152">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_08831"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00152">10.1021/acs.jmedchem.8b00152</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_001.csv">CSV</a>)</p></li><li><p class="inline">Additional information for the HPLC purity analysis conditions, experimental procedures for compounds <b>4–11</b>, <b>13–36</b>, and <b>38–42</b>, kinome profiles of compounds <b>25</b> and <b>26</b>, off-target profiles for compounds <b>4</b> and <b>37</b>, ACE/5HT1B functional profiles of compound <b>37</b>, ActivX kinome profile of compound <b>37</b>, and protein production, purification, and X-ray crystal structure data for compound <b>37</b> bound to the kinase domain of MAP4K4 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_001.csv">jm8b00152_si_001.csv (2.42 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00152/suppl_file/jm8b00152_si_002.pdf">jm8b00152_si_002.pdf (955.49 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates of the MAP4K4 kinase domain bound to compound <b>27</b> (PDB entry <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J95">5J95</a>) have been deposited with the Protein Data Bank.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00152&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00152%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00152" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679949713c6224eb","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
